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1INTRODUCTION
In 1898, August Bier first described "cocainisation of the spinal
cord". The technique has been refined over the years and has evolved into
the modern concept of intrathecal, spinal or subarachnoid block. One of
the  most commonly performed technique in modern anaesthesia is Central
neuraxial blockade.
In surgeries like hernioplasty the most preferred regional anaesthesia
is spinal anaesthesia. Spinal anaesthesia produces dense motor, sensory
and sympathetic blockade. Subarachnoid block is a preferred technique in
patients who are prone to aspiration like obesity, full stomach, GERD and
in patients with reduced respiratory drive. Spinal anaesthesia reduces
mortality and morbidity in high risk surgical patients.
Simplicity to perform and more rapid onset with good sensory as
well motor block(1), excellent analgesia and decreased stress response to
surgery and intra operative blood loss have made spinal anaesthesia
preferable in infraumbilical surgeries like hernioplasty. Most commonly
used amide local anaesthetic bupivacaine produces prolonged intense
sensory and motor block with significant sympathetic blockade and
excellent surgical relaxation(2, 3). Normally, spinal anaesthesia with
hyperbaric bupivacaine lasts for 2 to 2.5 hours(4). Commonly used dosage,
it produce more undesirable side effects(5): By reducing the dosage of
2bupivacaine, limits its distribution of spinal block, and it causes
comparably rapid recovery(6).
Various adjuvants are added to the local anaesthetics intrathecally,
to prolongate the duration of anaesthesia. Adjuvants not only reduce the
undesirable hemodynamic effects of spinal anaesthesia, by lowering the
requirement of local anaesthetic dose, but also provide satisfactory
block(7,8).
Among the adjuvants the most commonly preferred are the opioids.
These adjuvants have “synergistic anti-nocioceptive effect” along with
intrathecal local anaesthetic both during intra operative and post operative
periods by extending analgesia duration(9). Opioids act at the receptor site
in the spinal cord(10) and the local anaesthetics have their action at the
spinal nerve axon.
In 1979, Wang and his colleagues(11) first used intrathecal opioids
for acute pain treatment. Since then, intrathecal opioid is widely used to
increase the quality of Intraoperative anaesthesia, prolong the
postoperative analgesia, traumatic and chronic cancer pain. Administration
of intrathecal opioid  along with local anaesthetics is to improve the quality
of analgesia and to decrease the requirement of postoperative analgesics(12).
Various opioids have been used intrathecally like morphine,
fentanyl, buprenorphine and nalbuphine to fasten the onset and prolong the
duration of sensory and motor blockade.
3Nalbuphine  is synthetically prepared opioid. It has both agonist
and μ antagonist properties(13). When given intrathecally it binds to kappa
receptors in the spinal cord and brain. It produces analgesia and sedation
via kappa receptors and hence there is no adverse effects mediated by µ
receptors. Side effects like shivering, nausea, vomiting and urinary
retention are infrequent with nalbuphine hydrochloride. Nalbuphine
reaches ceiling effect at lower intrathecal dosage and so no need to
increase the dosage.
Fentanyl is a lipophilic μ receptor opioid agonist. Intrathecal
fentanyl as adjuvant to local anaesthetic has a rapid onset of action and
significantly reduces visceral and somatic pain which have been proved in
various studies(14, 15).
Although there are several studies that includes comparison of
Nalbuphine and fentanyl as adjuvant, there is no particular study in
patients undergoing hernioplasty.
In this study we compared the effectiveness of the two adjuvants
nalbuphine  and fentanyl added to 0.5% hyperbaric bupivacaine in patients
undergoing hernioplasty as Group A and Group B respectively, along with
a control group C of  intrathecal bupivacaine alone with normal saline.
4SUBARACHNOID BLOCK
Anatomy
Predictable sympathetic blockade, sensory analgesia or anaesthesia
and motor blockade are produced by central neuraxial blockade. It mainly
depends on the dose, volume and concentration of local anaesthetic
injected into subarachnoid space. To perform the technique of spinal
anaesthesia three dimensional understanding of anatomy is must.
The vertebral(spinal) canal, a bony structure that extends from the
foramen magnum to the sacral hiatus. The spinal cord and its nerve roots
are contained within the vertebral (spinal) canal. True vertebra consists of
C1-7 cervical, T1-12 thoracic and L1-5 lumbar vertebrae. The false
vertebra consists of the sacrum  5 fused segments and the coccyx 4 fused
segments.
There are four curvatures present in our adult spine. The major
importance of these curvatures are its major role in the distribution of local
anaesthetic solution in subarachnoid space. Vertebrae held together by
Intervertebral discs and series of overlapping ligaments.16,17 fig.1
The ligaments are namely:
1 Supraspinous ligament:
It connects the tip of each spinous process to the other.
2 Interspinous ligament:
It connects the vertebral spines
53 Ligamentum flavum :
It connects the lamina above and below
4 Anterior Longitudinal Ligament:
It Connects the front (anterior) of the vertebral body to the front
of the annulus fibrosus.
5 Posterior Longitudinal Ligament:
It connects the back (posterior) of the vertebral body to the back of
the annulus fibrosus.
Fig.1  VERTEBRAL LIGAMENTS.
Common palpable landmark that may corresponds to particular level
includes:
1. The most prominent spinous process in the cervical region -
corresponds to the 7th cervical vertebra.
62. Inferior angle of scapula usually corresponds to the seventh thoracic
vertebra and
3. The most important landmark used to determine the level for
insertion of spinal needle is Tuffier line.
Tuffier line: The line connecting the two iliac crests almost crosses the
vertebral column at the level of intervertebral space of fourth and fifth
lumbar vertebra.
Contents of Intervertebral canal are(18):
1. Roots of spinal nerves
2. Spinal membrane with the spinal cord and cerebrospinal fluid
3. Vessels, fat and areolar tissue
Spinal cord begins   from the rostral border of the medulla at the upper
border of atlas it begins and ends distally in the conus medullaris.(18,19,20)
There is differential growth rates between bony vertebral canal and
spinal cord. The cord terminates much higher than the bony canal.
Foetus: Length of cord Varies occupies  entire canal length.
Infants: upto L3 level
Adult : upto lower border of L1.
Below the conus, the roots  oriented parallel to  axis and resemble a
horse’s tail, from which the name cauda equina is derived.
7The spinal cord is surrounded  by three layers of connective tissue
known as the meninges :
 Duramater
 Arachnoid mater
 Piamater
Duramater is a tough fibro elastic membrane. It is  attached to
margins of foramen magnum above as an extension of cranial dura and
ends at  lower border of the S2 sacral vertebra. The  investing layer of
duramater is pierced by the anterior and posterior nerve roots from the
spinal cord.
The arachnoid mater is a thin transparent sheath. It is  closely
adherent to inner surface of the dura, imparts impermeability. It serves as
the major pharmacologic barrier and  prevents  movement of drug from the
epidural to the subarachnoid space.
The piamater is a highly vascular layer. It  is closely adherent to the
cord. It sends delicate septa into its substances. Filum terminale
(prolongated inferior end of piamater) penetrates the distal end of dural sac
and is attached to the periostium of coccyx.
The subarachnoid space lies between the arachnoid matter and the
piamater. Subarachnoid space is filled with the cerebrospinal fluid.
Cerebrospinal fluid is formed from the choroid plexus of lateral, third and
fourth ventricle. It contains the spinal nerve roots and the denticulate
8ligament. Lumbar puncture is done below the L2 vertebra to L3-L4
interspace.It is done at this level to prevent damage to spinal cord.
The spinal cord get its blood supply by three longitudinal arterial
channels:
 One anterior spinal artery.
 Two posterior spinal arteries the spinal cord.
Vertebral arteries are main contributers to the spinal arteries. It
reaches only till the cervical segment of the cord. Posterior spinal arteries
emerge from the cranial vault and it supplies the dorsal (sensory) portion
of the spinal cord and have rich collateral anastomotic
links from the subclavian and intercostal arteries, this area of the spinal
cord is relatively protected from ischemic damage. The spinal arteries also
receive blood through radicular arteries which accompanies the roots of
spinal nerves.
Among these radicular arteries only few are larger in size. Arteria
radicularis magna, or artery of Adamkiewicz, which is a highly variable
artery arises from the aorta in the lower thoracic or upper lumbar region. It
supplies blood to the lower two-thirds of the spinal cord. Injury of arteria
radicularis magna will cause anterior spinal artery syndrome. Thrombosis
in any of the anterior and posterior spinal arteries will cause spinal cord
infarction since they don’t have any anastomosis. Venous drainage of
spinal cord by six longitudinal venous channels.
9 Two paired anterolateral and posterolateral channels
 Unpaired anteromedian and posteromedian venous channels
Unpaired and paired venous channels forms venous plexus. Venous
blood drains from here via radicular veins into segmental veins.. These
veins prominent in the lateral epidural space and empty into the azygos
venous system.
SPINAL NERVES
Nerve roots merge to form 31 pairs of spinal nerves (8 cervical, 12
thoracic, 5 lumbar, 5 sacral, and 1coccygeal) distal to dorsal root ganglion.
The sensory fibers traverse the posterior aspect of the subarachnoid space,
so they tend to lie dependent in a supine patient, and thus making them
particularly vulnerable to hyperbaric solutions (heavier than CSF)
containing local anaesthetic. The dura traverses this area and becomes
thinned (often called the dural sleeve), thereby facilitating penetration of
local anaesthetic. Spinal block by local anaesthetics occurs by blockade of
sodium ion conductance in this region.
10
PHYSIOLOGY
CSF Circulation
Cerebrospinal fluid described by Galen as colorless fluid filling the
ventricles. The choroid plexus in the ventricles as the site of production of
CSF was first described by WEED. CSF is secreted at rate of 0.3 to
0.5ml/min. The average volume ranges from 120 to 150 ml, and it is in
cerebral subarachnoid space- 25ml,in the ventricles-35ml and   spinal
subarachnoid space -75ml
CSF Pathways
Cerebrospinal fluid transverses from the lateral ventricles into the
third ventricle through foramen of  monro and from there in to the fourth
ventricle through the aqueduct of sylvius. From the fourth ventricle it
reaches the subarachnoid space  through the median foramen of magendie
and the lateral foraminae of Luschka. The cerebral ventricles and the
subarachnoid space has functional communication only at the fourth
ventricle. It bathes Brain and spinalcord.
CSF Absorption
The absorption of CSF is a dual process, being chiefly a rapid
drainage through arachnoid villi, and arachnoid granulations of superior
sagittal sinus and its lateral lacunae into the great dural sinuses with small
contribution through a slow escape into the true lymphatic vessels by a
11
perineural course. About 300-380 ml of CSF enters venous circulation per
day.
Physical properties of CSF are:
pH: 7.32
Specific gravity at body temperature: 1.002-1.009
Specific gravity at 4 degree Celsius: 1.0003
Density: 1.0003gm/ml
Baricity: 1.000
CSF pressure: 50-180mm of H20
Spinal anaesthesia was introduced by AUGUST BIER in 1898.
Subarachnoid block produces:
 Sympathetic blockade
 Sensory blockade
 Motor blockade
12
Fig.2.   Structures pierced by spinal needle
Fig.3.Spinal needles
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Fig.4.Site of injection of Drug
BLOCK  LEVEL  REQUIREMENTS
Surgery Level required
Lower segment Cesarean section, Gynecological surgeries,
Intestinal surgery
T6
Hernioplasty/Urological surgeries :Transurethral resection of
prostate(TURP)/bladdertumor(TURB)
T10
Knee surgeries L1
Foot and ankle surgeries L2
Perineal and anal surgeries S2-S4
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ADVANTAGES OF SUBARACHNOID BLOCK
 Patient is conscious during surgery
 Lower incidence  of Nausea/Vomiting/sore throat
 Pain Control
 ↓incidence of DVT.
Indications of subarachnoid block
 Obstetric procedures.
 Gynecological procedures.
 Lower abdominal surgeries.
Orthopaedic surgery- all lower limb surgeries & few pelvic surgeries
Contraindications of subarachnoid block
Absolute contraindications:
Patient refusal.
Hypovolemia.
Increased intracranial pressure
Infection at the site of injection
Coagulopathy.
Indeterminate neurologic disease
Relative contraindications:
Major spine deformities or previous spine surgeries.
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Certain cardiac diseases if level above T6 are required.
Unknown duration of surgery
Infection distant from anatomic site of puncture.
POSITIONING
For technical ease and successful block proper positioning is very
important.
The various positions are
1. Lateral decubitus
2. Sitting (Fig.5)
16
Fig.5 Positioning  for spinal anaesthesia
Fig.6.sitting position
3. Prone (using hypobaric drug)
APPROACH
The different approaches are
1. Midline approach
In midline approach the needle is introduced in midline and is directed
slightly cephalad and piercing  the supraspinous ligament and the
ligamentum flavum is felt by popups.Then  the needle advancement
pierces the dura and then subarachnoid membrane as signalled by free
flowing CSF. Free flowing CSF is the best sign of correct lumbar puncture.
2. Lateral or Paramedian approach
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This approach is indicated in patients with positioning difficulty
(Kyphoscoliosis, Sclerotic lesions). In this approach the needle is inserted
1cm lateral and 1cm caudal to the inferior aspect of spinal process.
Fig.7.Lateral approach
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3. Taylor's approach
Paramedian type of technique. In this approach  the needle is directed
towards L5-S1 space and needle entry should be 1cm medial and 1cm
inferior to posterior superior iliac spine. Taylor’s approach is used in
conditions of  lumbar spine deformity.
Factors determining local anaesthetic spread21
Properties of local anaesthetics
 Baricity
 Dose
 Volume
 Specific gravity
 Concentration
Patient Characteristics
 Height of the patient
 Position of the patient during & after injection
 Spinal column anatomy
Cerebrospinal fluid Characteristics
 Cerebrospinal fluid composition
 CSF volume
Complications of spinal anaesthesia
 High/ total spinal anaesthesia
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 Failed spinal
 Patchy block or inadequate block
 Intravascular injection
 Neurotoxicity & neurological damage.
 PPDH-Postdural puncture headache
 Cardiovascular disturbances like hypotension, bradycardia.
 Back pain
 Arachanoiditis
 Cauda equine syndrome
Ratio between the density of a local anaesthetic solution at a specific
temperature, to the density of CSF at the same temperature is known as
BARICITY.  BARICITY determines the spread and distribution of local
anaesthetics in the CSF.
Baricity of less than 1 relative to CSF are Hypobaric solutions.
Hypobaric solutions are best choice for procedures in perineal or in prone
jack knife positions. Baricity equal to 1 are Isobaric solutions. Patient
positioning andGravity does not play a role in the spread of  Isobaric local
anaesthetics.
Baricity more than 1 relative to CSF are Hyperbaric solutions.
Hyperbaric solutions are denser than CSF. Patient positioning and Gravity
affect  the spread of Hyperbaric local anaesthetics.
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Local Anaesthetics :
Local anaesthestics when injected into the CSF, it bathes nerve root
in the subarachanoid space. Blockade of conduction in posterior nerve root
fibres interrupts the somatic & visceral sensation. Blockade of anterior
nerve root prevents efferent motor & autonomic outflow. Potency of the
drug, onset and duration of anaesthesia and its side effects determines the
choice of local anaesthetics. Rate of removal of local anaesthetics from
spinal cord tissue is determined by blood supply to the spinal cord tissue.
vascular absorption eliminates local anaesthetics from epidural space &
subarachnoid space. Faster the blood flow to spinal cord, more rapid is the
elimination of local anaesthetics.
21
OPIOIDS AND OPIOID RECEPTORS
Opioid derived from Greek word  “opos” means juice. Any
substance which acts on “Opioid receptors” and produces morphine like
effects, that blocked by antagonists such as naloxone, regardless of its
origin/structure is an Opioid. Opioid includes natural, semi synthetic and
synthetic agents.
From the juice of Papaver somniferous, the natural alkaloids opiates
like morphine, thebaine and codeine  are derived.
Fig.8. Papaver somniferum
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ENDOGENOUS OPIOIDS
Opioids found within the brain are endogenous opioids, which acts
through opioid receptor. Primarily there are three classes - enkephalins,
endorphins, and dynorphins.
CLASSIFICATION
NATURAL - Morphine, Codeine, Thebaine
SEMI SYNTHETIC - Dihydromorphone, Heroin ,Oxymorphone
SYNTHETIC - Pentazocine, Pethidine, Fentanyl,
Buprenorphine, Nalbuphine etc.,
Uses of opioids:
1. For Analgesia ( intraoperative and postoperative)
2. Used for premedicantion
3. Used as an Induction agent
4. Used for Sedation in ICU
5. Used to prevent and control shivering
6. Used as an adjuvant to local anesthetic in subarachnoid
block/Epidural.
Opioid Receptors:
Opioid receptors primarily mediate analgesic, and other effects of
opioid drugs (like morphine) and endogenous opioid peptides.  belongs to
the G protein-coupled receptor family. Inhibition of adenylate cyclase(22),
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and reduction of cellular cyclic adenosine monophosphate content are
mediated by them.
SUB TYPES OF OPIOID RECEPTORS
Opioid receptors(23) are subdivided into three subtypes. They are :
mu(μ), kappa(κ), delta(δ).
mu(μ) receptors - gene on chromosome 6. They are subdivided into μ1,
μ2, μ3.
µ1 : mediates analgesia and physical dependence.
µ2 : mediates respiratory depression,miosis, constipation, euphoria.
µ3 : vasodilation,increase GH and prolactin secretion.
kappa(κ) receptors - gene on chromosome 8.
They are subdivided into κ 1, κ 2, κ 3.
They mediates analgesia, dysphoria, miosis, sedation, diuresis.
delta(δ) receptors - gene on chromosome 1 and 4.
They mediates analgesia, respiratory depression, dependence.
Newer opioid receptors
Nociceptin receptor
Zetta receptor.
Based on receptor interaction opioids are classified:
1. Pure agonist (+),
2. Mixed agonist / antagonist (+/-) and
3. Pure Antagonist (-).
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In Spinal
Their action is in substantia gelatinosa of dorsal horn cells.
Inhibition of substance P release.  Inhibition of the ascending transmission
of nociceptive stimuli.
Peripheral mechanisms
1. Stimulates G protein synthesis and increase cAMP which causes
2. Raises K+ - Hyperpolarization of membrane
3. Diminished Ca2+ - Excitability
Fig.9. Site of action of opioids
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PHARMACOLOGY OF FENTANYL24, 25
Synthetic opioid receptor agonist. Comparatively fentanyl is 75-125
times more potent than morphine.
Fig.10.chemical structure of fentanyl
Chemical structure of fentanyl
Fentanyl is PHENYL PHERIDINE DERIVATIVE with nucleus
containing PHENANTHERENE structure as in fig.9
Mechanism of action:
Fentanyl is highly lipophilic synthetic compound. It has pure agonist
action on stereotypic μ type opioid receptor, both at presynaptic and post
synaptic sites of central nervous system and peripheral tissue. Fentanyl
cause presynaptic inhibition of neurotransmitter (Ach, Dopamine,
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Norepinephrine, substance P) release, by increasing potassium
conductance and by calcium channel inactivation.
Fentanyl also inhibits the release of excitatory neurotransmitter like
substance P. Effect is produced by inhibiting adenylcyclase hence
decrease neurotransmitter release.
Dose and mode of administration
Fentanyl is a major component of balanced anaesthesia
 1-2mcg/kg  for intravenous analgesia
 25mcg (maximum) for  intrathecal
 5-20mcg/kg for  oral/transmucosal
 75-100mcg/hr for  transdermal
The plasma concentration of fentanyl should be around 20-30ngm/ml for
maximum analgesia.
Pharmacokinetics
Fentanyl is very highly lipophilic, so crosses the blood brain barrier
easily, hence it has rapid onset of action and greater potency. Volume of
distribution is very high & hence it is very short acting. Fentanyl gets
rapidly distributed to fat, skeletal muscles and pulmonary tissue. With
continuous infusion or multiple dosages the saturation of tissue occurs & it
will produce prolonged duration of action. Intrathecally given fentanyl
produces selective segmental analgesia, by blocking opioid receptors of
dorsal horn. Duration and amount of analgesia depends upon the drug
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concentration. Lower dose of fentanyl is required for intrathecal
administration than the systemic dosage & so the side effects are minimal.
But some systemic side effects do occur, it’s because of cephalad
migration of drug and vascular or tissue uptake. Fentanyl is smaller
molecule and lipophilic hence readily crosses placenta.
pKa of fentanyl —8.4, Protein binding-80%, Clearance-1530ml/min,
Volume of distribution- 335litres, Elimination half-life- 31.66 hrs Context
sensitive half-life after 4 hours of infusion- 260 minutes.
Metabolism
90% of fentanyl is metabolized in liver by N-Demethylation to
produce Norfentanyl, hyroxy proprionyl fentanyl, hyroxy Proprionyl nor
fentanyl. These products are minimally active.
Excretion
Excretion is mainly by kidneys. Only 10% is excreted
unmetabolized. Metabolites are seen in urine even after 72 hrs.
Elimination half life
80% of  the drug eliminates from plasma in less than 5 minutes as
it is highly lipid soluble. The plasma concentration is reached only by
redistribution hence it has a longer half life.
Context sensitive half life
Half life is prolonged if the drug is given as infusion for greater than
2 hrs as the peripheral tissues become saturated.
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Pharmacodynamics
Central Nervous System
Rapid IV injection of fentanyl may produce seizure like activity. On
EEG monitoring they were found to be myoclonus due to inhibition
neurons of temporal lobe. It produces skeletal muscle rigidity. At normal
Paco2, it produces rise in intracranial pressure by 6-9mmhg associated
with fall in mean arterial pressure(MAP) and cerebral perfusion pressure
due to autoregulatory reduction in cerebral vascular resistance. Muscle
rigidity caused by μ receptors of brain stem, midline nuclei and basal
ganglia.
Cardiovascular System
Fentanyl given in high dose depresses isolated myocardial
contractility, but at normal dose it does not produce direct myocardial
depression. Fentanyl markedly depresses the Carotid sinus baroreceptor
reflex control of heart rate. Fentanyl does not cause histamine release as
with other opioids such as morphine or pethidine. Fentanyl has
vagomimmetic action and it produces dose dependent fall in heart rate,
even cause severe bradycardia or asystole is noted at high doses. It
suppress  the central sympathetic outflow & it produces dose dependent
fall in blood pressure.
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Respiratory System
Fentanyl produces dose dependent suppression of respiratory centre
& cause reduction in tidal volume and minute ventilation. Redistribution of
the drug from the peripheral tissue may cause severe delayed respiratory
depression in the post-operative period.
Gastrointestinal System
Fentanyl decreases gastrointestinal motility & hence causes
constipation. Fentanyl by direct stimulation of chemoreceptor trigger zone,
produces nausea and vomiting.
Pruritis
Fentanyl produces intense pruritis which seems to be mediated by μ
type opioid receptor.
Uses of fentanyl:
 Used for sedation in ICU setup
 Used for Surgical analgesia
 Used along with inhalation agents in balanced anaesthesia
 Very high dose in IHD patients as induction
 Used for blunting intubation stress response
 Used as adjuvant in regional anaesthesia
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Adverse Effects of fentanyl:
Persistent respiratory depression or recurrent respiratory depression
in post operative periods, prominent fall in heart rate(HR), fall in blood
pressure, rigidity and myoclonus, raised Intracranial pressure, reflex
coughing
PHARMACOLOGY OF NALBUPHINE
To overcome the abuse potential, many synthetic opioids were
developed. Those synthetic opioid substances are referred to as mixed
agonist-antagonist analgesics. Nalbuphine comes under them.
CHEMISTRY
Nalbuphine hydrochloride,is a synthetic narcotic agonist-antagonist
analgesic of phenanthrene series. Chemically, nalbuphine is related to the
opioid antagonist naloxone and opioid agonist oxymorphone. Nalbuphine
hydrochloride is soluble in water at 250C, ethanol 0.8% and available only
as an injectable solution.
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CHEMICAL STRUCTURE
Fig.11.chemical structure of nalbuphine
CHEMICAL NAME
17 - (cyclobutylmethyl) - 4, 5 - epoxy, morphinan-3, 6,1 4 - triol,
hydrochloride
RECEPTOR INTERACTION
Nalbuphine hydrochloride binds to mu(μ), kappa(κ), and delta(δ)
receptors, but not to sigma receptors. Nalbuphine hydrochloride is
primarily a κ agonist/μ antagonist analgesic. Nalbuphine hydrochloride has
an analgesic potency(26) similar to that of morphine. The narcotic
antagonist activity of nalbuphine hydrochloride is nearly one-fourth(1/4th)
as potent as that of nalorphine and it is ten times potent as that of
pentazocine. When nalbuphine administered subsequent or concurrent
with μ agonist opioid analgesics (e.g., morphine, fentanyl), it may partially
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reverse or block opioid-induced respiratory depression from the μ agonist
analgesic.
MECHANISM OF ACTION
By its agonist action, nalbuphine hydrochloride stimulates κ
receptors & thereby it inhibits the release of neurotransmitters like
substance P that mediate pain. Nalbuphine acts as a post-synaptic inhibitor
on the "inter neurons & output neurons" of the Spino-thalamic tract which
transports nociceptive information.
PHARMACEUTICAL INFORMATION
Molecular formula - C21 H27 NO 4 .HCl
Molecular Mass - 393.91 g/mol
pKa - 8.71
PHARMACOKINETICS
Nalbuphine hydrochloride is inactive orally and intravenous route is
the conventional route of administration. Nalbuphine can also be
administered by intramuscular, subcutaneous, neuraxial routes. Bio-
availability is around 80%. Volume of distribution(Vd) is 3.8litres/kg.
Onset of action Intravenous administration is within 2-3 mins & by
subcutaneous, intramuscular it is < 15 mins
Plasma half life - 5 hrs. Duration of analgesia - 3 to 6 hrs. Nalbuphine
hydrochloride is primarily metabolized in the liver and the metabolites are
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excreted via kidney. The dosage of nalbuphine must be decreased in
patients with hepatic and renal failure.
USES OF NALBUPHINE
 Used as an adjuvant to general anesthesia
 Used as an adjuvant to neuraxial anesthesia
 Used for Obstetric analgesia during labor and delivery
 Used as an adjuvant to peripheral nerve blocks.
 Used in the management of postoperative pain.
ALSO  USED FOR:
 Opioid induced pruritus and respiratory depression(27)
 Shivering
 Sickle cell anemia with crisis
PREPARATIONS AND STORAGE
 It is available as 10mg, 20mg solutions in 1ml ampoule.
 It should be stored at room temperature (15°c to 30°c).
 To be protected from excessive light.
Fig.12.Ampoule of nalbuphine
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ADVERSE EFFECTS
The most common side effects of nalbuphine hydrochloride are
sedation, sweating, nausea, vomiting, dizziness, vertigo, dry mouth,
headache. Other side effects are bradycardia, hypotension, urinary urgency.
Because of the ceiling effect,(28) nalbuphine hydrochloride causes less
respiratory depression compared to other opioids.
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REVIEW OF LITERATURE
Literature related to intrathecal adjuvants added to local
anaesthetics was searched in google, pubmed, medknow and metascape
search engines using keywords like intrathecal nalbuphine, intrathecal
fentanyl, intrathecal adjuvants added to bupivacaine , from articles 2000 to
till date.
1. Mukherjee A, Pal A, Agrawal J(29) et al conducted a study in 2011
titled "Intrathecal nalbuphine as an adjuvant to subarachnoid block:
What is the most effective dose?". It was a randomized, prospective
double blind controlled study. Patients of ASA physical status I and
II posted for elective lower limb orthopedic surgery under spinal
anaesthesia were included in the study. They allotted into 4 groups
A,B,C and D by computer generated randomisation.
12.5mg -0.5% hyperbaric bupivacaine added to 0.2,0.4,0.8mg of
nalbuphine and normal saline respectively according to the group
allotted.
They compared the onset of sensory blockade and motor
blockade and the duration of sensory blockade and motor blockade
between the groups. They used Bromage scale for assessing motor block
and visual analogue scale for assessing pain. The onset time of sensory
blockade and motor blockade was significantly (p<0.05) reduced and the
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duration of block was prolonged in nalbuphine groups. They observed
that when nalbuphine was added as an adjuvant the analgesic effect of
bupivacaine was significantly prolonged. The authors observed and
concluded that 0.4mg nalbuphine is the most effective intrathecal dose
that increases the duration postoperative analgesia with no side-effects.
2. Jyothi B, Shruthi Gowda, Safiya Shaikh(30) did a study in 2014 titled
"A comparison of analgesic effect of different doses of intrathecal
nalbuphine hydrochloride with bupivacaine and bupivacaine alone
for lower abdominal and orthopedic surgeries". Hundred patients of
both sexes under ASA I and II were included in the study. They
were randomly allocated into 4 groups I, II, III, IV. Study was a
double blind randomized controlled study. Prior to Subarachnoid
block, monitors like ECG, pulse oximetry (pulse rate,Spo2), non
invasive blood pressure (NIBP) were connected. Base line values
were recorded. Under SAB, 15mg bupivacaine + 0.5ml of
NS(Group I) or 15mg of bupivacaine with any of nalbuphine dosage
0.8mg, 1.6 and 2.5mg (Group II,III and IV) was given. The two
segment regression time of sensory blockade was increased and
duration of analgesia was significantly prolonged in nalbuphine
groups. The postoperative pain scores were drastically reduced in
group II ,III & IV than group I (3.4±0.4 vs 4.08±0.5). Finally they
concluded that addition of 0.8mg nalbuphine to 0.5% hyperbaric
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bupivacaine intrathecally provides excellent and prolonged
analgesia. No significant side effects.Analgesic ceiling effect noted
at 0.8mg dosage, and further increase in dose didn’t rise the
analgesic efficacy.
3. Shehla shakooh, Pooja Bhosle(31) conducted a study in 2004 titled
"Intrathecal nalbuphine; An effective adjuvant for post operative
analgesia". It was a prospective randomized double blind study. 60
patients under ASA Physical Status I and II posted for elective
lower abdominal surgery and lower limb surgery were enrolled in
the study. Patients were divided into 2 groups by slips in the box
technique. Group N received 0.5% heavy bupivacaine (3cc) + 0.8mg
nalbuphine, Group B received 0.5% heavy bupivacaine (3cc).
Hemodynamic parameters HR, spo2,NIBP were observed
throughout the procedure. Sensory block and motor block were
assessed by pinprick and Bromage scale respectively. The authors
concluded that the onset of sensory blockade and motor blockade
were earlier in group N with a significant p value (0.001). The
duration of sensory blockade & motor blockade and the
postoperative analgesia duration were superior in group N
(nalbuphine group) as compared to group B. No significant side
effects were reported between the two groups.
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4. Mostafa Galal, Mohamad F(32) et al did a study in 2011 regarding
"Which has greater analgesic effect: Intrathecal Nalbuphine or
Intrathecal Tramadol?". 60 patients posted for Transurethral
resection of the bladder tumor (TURBT) under the ASA PS I and II
were included in the study. They were randomly divided into 2
groups.Received 15mg of 0.5% hyperbaric bupivacaine + 50mg of
tramadol hydrochloride preservative free/2mg of nalbuphine
hydrochloride preservative free  according to the group allotted..
Subarachnoid block was performed with 25G Quincke's needle in L3-
L4 space with Patient in right lateral decubitus position. They studied
postoperative analgesic requirements, sedation scores & Visual Analog
Scale (VAS) for pain intensity and side effects.
The authors finally concluded that intrathecal tramadol and intrathecal
nalbuphine when used with bupivacaine 0.5% produce similar
postoperative analgesia, however the sedation scores were higher in
tramadol group.
5. Ravikiran J Thote, Prashant Lomate, Shilpa Gaikwad(33) et al
conducted a study in 2015 titled " Comparison among intrathecal
fentanyl and nalbuphine hydrochloride in combination with
bupivacaine and plain bupivacaine for lower limb surgeries". It was
a prospective randomized controlled double blind study. 60 patients
of both sexes posted for lower limb surgeries under ASA Physical
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status I and II were included in the study. They were segregated into
three groups of twenty patients each using computer generated
random numbers. They compared 25mcg of fentanyl and 500mcg of
nalbuphine added to 2.5ml of 0.5% hyperbaric bupivacaine and
with Group III - received 2.5ml of 0.5% hyperbaric bupivacaine +
0.5ml of normal saline.
They finally concluded that the onset of sensory
blockade and motor blockade were significantly earlier in fentanyl
and nalbuphine group. However the duration of sensory blockade
was prolonged with nalbuphine bupivacaine combination than
fentanyl bupivacaine combination. Sedation at the level of
arosoubility without any respiratory depression was noted with
nalbuphine.
6. Bindra TK, kumar P et al(34) conducted a study in 2018 titled
“postoperative analgesia with Intrathecal Nalbuphine versus
Intrathecal Fentanyl in cesarean section:” A Double –blind
Randomized comparative study.
In this study 150 parturients of ASA PS I and II of age group 20-45yrs
with normal coagulation profile undergoing cesarean section under spinal
anaesthesia were enrolled. These Patients were randomized into three
groups. Group I,II,III & each group of fifty patients. They received 2ml
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bupivacaine + 0.4ml nalbuphine (groupI) /0.4ml fentanyl(group II)/0.4ml
normal saline (group III)respectively.
They finally concluded both intrathecal nalbuphine 0.8mg and
fentanyl 20µg are effective adjuvants to 0.5% heavy bupivacaine.They also
concluded that the duration of analgesia is maximally prolonged by
nalbuphine when compared to fentanyl and hence nalbuphine may be used
as an alternative to fentanyl in cesarean section.
7. Chatrath V, Attri(35) et al performed a study in 2015 regarding "The
effect of epidural nalbuphine for postoperative analgesia in
orthopedic surgery". A study was performed with 80 adult patients
of (ASA) PS I and II category posted for elective lower limb
orthopedic surgeries under combined spinal & epidural anaesthesia.
Patients were divided into two categories using computer
randomization method. Patients received epidurally 10ml of 0.25%
bupivacaine + 10mg nalbuphine or 100mg tramadol.
Subarachnoid block (SAB) was given with 0.5% of 2.5ml
bupivacaine in both the groups. Epidural top up was given at sensory
regression to T10. Mean duration of analgesia & mean sedation score were
compared between the two groups. They finally concluded that the quality
of analgesia and patient satisfaction score were better with nalbuphine
epidurally than with epidural tramadol.
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8. Hala Mostafa Gomaa, Nashwa nabil Mohamed(36) et al did a study in
2013 titled "A comparison between post-operative analgesia after
intrathecal nalbuphine with bupivacaine, and intrathecal fentanyl
with bupivacaine after cesarean section". 60 pregnant females posted
for elective LSCS under the ASA PS II were included in the study.
The patients after obtaining informed consent were divided into 2
groups. Patients received 0.5% hyperbaric bupivacaine + 0.5ml
fentanyl(25μg) intrathecally or 0.5ml nalbuphine
hydrochloride(0.8mg) intrathecally according to the group allotted..
They finally concluded that time for to reach the T10 sensory
segment was not significantly different between the two groups
(F&N). However, the duration of intraoperative analgesia &
postoperative analgesia was prolonged in group N compared to
group F.
9. Pallavi Ahluwalia, Amit Ahluwalia(37) et al performed a study in
2015 titled "A prospective randomized double-blind study to
evaluate the effects of intrathecal nalbuphine, in patients of lower
abdominal surgeries under spinal anaesthesia". They conducted
study in 70 adult patients posted for lower abdominal surgeries who
were enrolled in the study. They were randomly divided into two
groups (GroupN&Group C). Group N received 2.5ml of 0.5%
hyperbaric bupivacaine + nalbuphine 0.8mg (made upto 0.5ml)
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intrathecally. Group C received 2.5ml of 0.5% hyperbaric
bupivacaine + normal saline (0.5ml) intrathecally. They concluded
that the addition of nalbuphine as adjuvant to bupivacaine
intrathecally fastens the the time of onset of sensory blockade
(1.29±0.43min vs 3.78±1.31min) and prolongs the duration of
sensory blockade and motor blockade. The time to first analgesic
requirement was prolonged in group N (nalbuphine group) as
compared to group C (298.43±30.92min vs 201.31±34.31min).
10. Xavier Culebras, Giovanni Gaggero(38) et al did a study in 2000
titled "Advantages of Intrathecal Nalbuphine, Compared with
Intrathecal Morphine, After Cesarean Delivery: An Evaluation of
Postoperative Analgesia and Adverse Effects". After the approval
from ethical committee and getting informed consent, 90 healthy
parturients at term for elective cesarean delivery under spinal
anaesthesia were enrolled in the study. It was a randomized,
prospective double blinded study. Patients received 10mg of 0.5%
hyperbaric bupivacaine with either morphine 0.2mg (category A),
nalbuphine 0.2mg (category B), nalbuphine 0.8mg (category c) &
nalbuphine 1.6mg (categoryD).
They found that postoperative analgesia was significantly
prolonged in the  morphine category than nalbuphine (P < 0.0001). Among
the nalbuphine categories, postoperative analgesia was prolonged with
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0.8mg (category c). Adverse effects like pruritus, nausea and vomiting
were more with morphine when compared to nalbuphine. APGAR scores
were similar in all groups. There was no newborn or maternal respiratory
depression with both groups. The authors had finally concluded that 0.8mg
intrathecal nalbuphine provides good intraoperative analgesia and
improves postoperative analgesia without adverse effects.
11.Gurunath BB et al(39)., conducted a study in 2018 titled
“Postoperative analgesic efficacy of intrathecal fentanyl, compared
to nalbuphine with bupivacaine in spinal anaesthesia for lower
abdominal surgeries”. In this study 124 patients aged 18-55yrs under
ASA PS I and II were randomized into 2 groups, Group N and
Group C and they received nalbuphine (300µg) + hyperbaric
bupivacaine  & fentanyl (25 µg) + hyperbaric bupivacaine
respectively. They concluded that Group N nalbuphine 300µg with
3ml of0.5% hyperbaric bupivacaine  had  increased in onset time of
sensory blockade and had increased duration of postoperative
analgesia, increased duration of sensory blockade and minimal
bradycardia  that could be managed easily.
12. Moustafa AA, Baaror AS, Abdelazim IA(40) et al did a study titled
"Comparative study between nalbuphine and ondansetron in
prevention of intrathecal morphine -induced pruritus in women
undergoing cesarean section". 90 pregnant women of ASA PS II
44
scheduled for cesarean delivery under spinal anaesthesia (SAB)
were recruited for this study. They were divided into three groups.
SAB performed in left lateral position at L3-4 interspace using 25G
Quincke spinal needle with 2.2ml of 0.5% hyperbaric bupivacaine
and 0.2mg morphine. Immediately after delivery of baby they
received one of the following
 Placebo group (P) - received 4ml of normal saline(NS) IV injection.
 Nalbuphine group (N) - received 4ml of 4mg nalbuphine IV.
 Ondansetron group (O) - received 4ml of 4mg ondansetron IV.
Patients were observed for pruritus scores, blood pressure, heart rate and
SPO2 in the post anaesthesia care unit (PACU) for 4 hours. Both
nalbuphine and ondansetron were effective for prevention of intrathecal
morphine induced pruritus in parturients undergoing cesarean delivery.
However among nalbuphine &  ondansetron, nalbuphine was preferred
because it is not excreted in breast milk.
13. Rajni Gupta et al(41) (2011) with an aim to evaluate the onset and
duration of sensory block and motor block, hemodynamic effect,
postoperative analgesia, and adverse effects of dexmedetomidine or
fentanyl given intrathecally as adjuvant with 0.5% hyperbaric
bupivacaine conducted a study in 60 patients classified in ASA PS
I and II scheduled for lower abdominal surgeries. Patients were
randomly alloted to receive either 12.5 mg hyperbaric bupivacaine +
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5μcg dexmedetomidine (group D, n=30) or 12.5 mg hyperbaric
bupivacaine + 25 μcg fentanyl (group F, n=30) intrathecal. The
mean time of sensory regression to reach S1 level was 476±23 min
in group D and 187±12 min in group F(P<0.001). The regression
time of motor block to reach modified Bromage score 0 was
421±21 min in group D and 149±18 minutes in group F (P<0.001).
They finally concluded that intrathecal dexmedetomidine was
associated with prolonged motor block and sensory block,
hemodynamic stability, and reduced demand for rescue analgesics in
24 hrs when compared to fentanyl.
14. Hem Anand Nayagam et al (42)(2014) did a prospective randomized
double blind study of intrathecal fentanyl & dexmedetomidine added
to low dose bupivacaine for spinal anaesthesia for lower abdominal
surgeries in one hundred & fifty patients. Group F (n = 75) received
bupivacaine 0.5% hyperbaric (0.8 ml) + fentanyl 25 μcg (0.5 ml) +
normal saline 0.3 ml and Group D (n = 75) received bupivacaine
0.5% hyperbaric (0.8 ml) + dexmedetomidine 5μcg (0.05 ml) +
normal saline 0.75 ml, aiming for a final concentration of 0.25% of
bupivacaine (1.6 ml), administered intrathecally. Time taken to
reach T10 block level, peak sensory block level (PSBL), time taken
to reach peak block level, time taken to two segment regression
(TTSR), the degree of motor block (MBS), side-effects and the time
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to first analgesic request (TFAR) were recorded. PSBL (P = 0.000)
and TFAR (P = 0.000) were highly significant. Mean time to PSBL
(<0.05) and MBS (P = 0.035) were significant. They finally
concluded that the clinical advantage of dexmedetomidine over
fentanyl. Dexmedetomidine facilitated the spread of the block and
offered prolonged post operative analgesia compared to fentanyl.
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AIM OF THE STUDY
The aim of the study was to  Compare  intrathecal nalbuphine vs
fentanyl added to 0.5% hyperbaric bupivacaine for perioperative
anaesthesia and postoperative analgesia in patients undergoing
hernioplasty.
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OBJECTIVES
Objective of the study was to compare the
Outcome measures:
Primary measure:
Sensory block onset time (sensory level T10)
Motor block onset time(Bromage 3)
Highest level of sensory block reached and time taken to
reach it.
Time taken for two segment regression of sensory level
Duration of motor block
Duration of analgesia
Secondary measure:
Haemodynamic parameters
Side effects
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MATERIALS AND METHODS
This study was done in Tirunelveli medical college hospital,at
Department of  Anaesthesiology and critical care from December 2017 to
September 2018.
STUDY DESIGN
It was a Single centre, prospective, randomized double blinded,
interventional controlled study.
After obtaining institutional ethical committee approval, 120 patients
posted for elective hernioplasty surgery under spinal anaesthesia with
satisfying inclusion criteria were enrolled in the study after obtaining
informed consent from the patients and relatives.
RANDOMIZATION :
3 Groups by random number allotted by slips in the box technique
ALLOCATION & INTERVENTION: 3 Groups
n = 40
Group A : 15mg (3 ml) of 0.5% hyperbaric bupivacaine and
nalbuphine 0.5 mg (0.5ml) - Total volume 3.5 ml.
Group B received 15mg (3 ml) of 0.5% hyperbaric bupivacaine and
fentanyl 0.25 mcg (0.5ml) - Total volume 3.5 ml.
Group C received 15mg (3 ml) of 0.5% hyperbaric bupivacaine and
normal saline 0.5 ml (0.5ml)- Total volume 3.5ml
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INCLUSION CRITERIA
 20 - 60 years of age
 ASA physical status I or II
 Patients who gave valid informed written consent
 Patients undergoing elective hernioplasty.
EXCLUSION CRITERIA
 Patients having any absolute contraindications for spinal anaesthesia
 Infection at the subarachnoid block injection site
 Patients with neurological and musculoskeletal disease
 Patients with bleeding disorders
 Patients on anticoagulants
 History of allergy to local anaesthetics and Obese patients (obesity
BMI > 30kg/m2).
PRE-OPERATIVE ASSESSMENT
All the patients were duly examined on the day prior to surgery and
pre-operative assessment sheet was checked. The height (cms), weight(kg),
body mass index(BMI), of the patient were measured. The airway
assessment, spine examination and the nutritional status of the patient were
evaluated. A detailed general and systemic examination was done.
Preoperative investigations like complete haemogram (CBC), renal
function tests(RFT), random blood sugar, blood grouping and typing,
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coagulation profile, electrocardiography and chest X ray were evaluated
properly.
PREMEDICATION
All the patients were fasted overnight. They were pre-medicated
with  tablet ranitidine 150mg, tablet metoclopramide 10mg, and tablet
alprazolam 0.5mg on the night before surgery.
PREPARATION
Upon arrival to the operating room, standard monitors like non
invasive blood pressure(NIBP), Electrocardiography(ECG) and pulse
oximetry(SPO2) were connected and baseline values were recorded. An
intravenous line was secured with 18G cannula. After securing iv line,
patients were preloaded with10ml/kg of Ringer Lactate (RL) solution.
TECHNIQUE:
The patient was placed in the right lateral decubitus position. Under
strict aseptic precautions, lumbar puncture was performed at L3-L4
intervertebral space using 25 G quincke’s needle using the midline
approach. After confirming free flow of clear cerebrospinal fluid(CSF),
drug was injected at 0.2ml/sec, according to the groups allocated as
described above.
Oxygen at 4l/min was administered through face mask.
Hemodynamic parameters like peripheral oxygen saturation(spo2), non
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invasive blood pressure(NIBP), pulse rate were recorded at regular
intervals intraoperatively and postoperatively.
MONITORING
 Hypotension was defined as  systolic blood pressure less than 90mm
Hg or less than 20% from baseline, which was  treated with Inj.
Ephedrine 6mg iv bolus.
 Bradycardia was defined as heart rate less than 60 beats/min, which
was  treated with - Inj. Atropine 0.6 mg iv bolus.
Sensory block was assessed by pinprick method in the mid-
clavicular line using 27G needle, every minute until the block reached T6
dermatome. After that, level was checked every 2 mins until maximal
sensory block was attained.
GRADES OF SENSORY BLOCKADE
GRADE 0 - Sharp pain is felt
GRADE 1 - Analgesia, dull sensation is felt
GRADE 2 - Anesthesia, no sensation is felt
Onset of sensory blockade was defined as the time interval between
the end of anesthetic injection to loss of sensation to pinprick at T10 level.
MOTOR BLOCKADE
The quality of motor block was assessed by modified Bromage scale.
GRADE 0 - no motor blockade, patient able to lift the leg at the hip.
GRADE 1 – patient able to flex the knee and ankle but not able to lift the
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leg at the hip (hip blocked)
GRADE 2 -patient able to move the foot only (hip and knee blocked)
GRADE 3 –patient unable to move even the foot (hip, knee and ankle
blocked ).
Onset of complete motor blockade was defined as the time interval
taken between the completion of study drug injection until Bromage 3 was
registered.
Surgery was started after complete anaesthesia was attained. At the
end of the surgery, both sensory and motor level were noted. Time taken
for two segment regression from the maximal level was noted.
Postoperatively, patients were regularly followed up and monitored in the
recovery and postoperative ward.
VISUAL ANALOG SCALE
Before surgery patients were explained about Visual Analog
Scale(VAS) . The scores were periodically evaluated in the postoperative
ward and rescue analgesia was given at a VAS score of 4 or more.
Fig.14.  VISUAL ANALOG SCALE
54
0-10 VAS Numeric Pain Distress Scale
SCORE 0-2 =NO PAIN
SCORE 2-4= MILD PAIN
SCORE 4-6= MODERATE PAIN
SCORE 6-8 =SEVERE PAIN
SCORE 8-10 =UNBEARABLE PAIN
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STATISTICS AND RESULTS
Statistical Analysis:
Data were analysed with SPSS version 16 and Microsoft excel.
Comparison of three groups were done by using one way Anova.
Descriptive results were calculated using mean and standard deviation. An
P  value of less than 0.05 was considered statistically significant. Sample
size was calculated using the formula n=(u+v)2 ×(SD1²+SD2²)÷(µ1-
µ2)with  atleast 90 sample size needed to detect a difference with more
than 80% power of study at 5% significance level.
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OBSERVATION AND ANALYSIS
All 120 patients with ASA physical status I/II who satisfied all
inclusion criteria were randomly divided into three groups and underwent
Hernioplasty under subarachnoid block in Tirunelveli medical college
Hospital, attached to Tirunelveli Medical College, Tirunelveli. All the
patients completed the study without any exclusion.
The collected data were analyzed by one-way ANOVA and results
obtained in form of mean and standard deviation. The probability value p <
0.05 is considered as statistically significant. comparison of  the resuts :
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DEMOGRAPHIC DATA
Demographically all patients were comparable with regards to age,
height and weight.
Age distribution
Mean age in three groups were around 44 . The p value for mean
age was not stastitically significant (p value = 0.418).
Age distribution
AGE No of Patients Mean(Years) Std. Deviation P value
Group A 40 44.13 10.84
0.418
Group B 40 45.83 9.22
Group C 40 42.58 12.60
Total 120 44.18 10.96
Tab 1: Age distribution
Chart 1: Age Distribution
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40.00
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Height Distribution:
Mean height was not statistically significant, (p value=0.202).
Height No of Patients Mean
(CM)
Std. Deviation P value
Group A 40 165.08 3.54
0.202
Group B 40 165.28 3.40
Group C 40 163.98 3.49
Total 120 164.78 3.50
Tab.2. Height distribution(height in cms)
Chart 2: HEIGHT DISTRIBUTION
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WEIGHT DISTRIBUTION
Mean weight was not statistically significant, (p value=0.652).
Weight No of Patients Mean
(Kg)
Std. Deviation P value
Group A 40 63.98 5.06
0.652
Group B 40 64.90 3.77
Group C 40 64.53 3.92
Total 120 65.13 4.44
Table .3 Weight Distribution
Chart 3: Weight distribution
GROUP A - BUPIVACAINE + NALBUPHINE
GROUP B - BUPIVACAINE + FENTANY
GROUP C - BUPIVACAINE + NORMAL SALINE
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ASA status comparison
Table.4  ASA status comparison
Chart 4: ASA status
GROUP A - BUPIVACAINE + NALBUPHINE
GROUP B - BUPIVACAINE + FENTANYL
GROUP C - BUPIVACAINE + NORMAL SALINE
ASA - American Society of Anesthesiologist
16
21 19
24
19 21
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No
 of
 Pa
tie
nts
I II
GROUP ASA Total P value
I II
Group A 16 24 40
0.529Group B 21 19 40
Group C 19 21 40
Total 56 64 120
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Sensory block onset time comparison:
SOT N Mean Std. Deviation P value
Group A 40 3.05 0.88
<0.0001
Group B 40 2.25 0.63
Group C 40 4.08 1.25
Total 120 3.13 1.21
Table.5.SOT comparison
Dependent Variable Mean Difference
(I-J)
P value
SOT Group A Group B 0.80 0.001
Group C -1.03 0.000
Group B Group A -0.80 0.001
Group C -1.83 0.000
Group C Group A 1.03 0.000
Group B 1.83 0.000
Table.6. SOT multiple comparison
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Chart 5: SOT comparison
Comparison of mean time of onset of  sensory block is statistically
significant among three Groups (P value <0.0001) . Sensory block onset
time of Group B is much earlier than Group A and it is statistically
significant (P value 0.001). Sensory block onset time of Group A is much
earlier than Group C and it is statistically significant (P value 0.000).
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Comparison of  Time to reach highest level of sensory block:
THSL N Mean Std. Deviation P value
Group A 40 13.75 2.06
0.002
Group B 40 11.68 2.44
Group C 40 14.54 3.54
Total 120 12.92 2.87
Table.7.THSL comparison
Dependent Variable Mean Difference
(I-J)
P value
THSL Group A Group B 2.08 0.003
Group C -0.79 0.125
Group B Group A -2.08 0.003
Group C -2.82 <0.0001
Group C Group A 0.79 0.125
Group B 2.82 <0.0001
Table.8.THSL multiple comparison
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Chart 6: THSL comparison
Comparison of mean time to reach highest sensory level among three
Groups is statistically significant (P value0.002). Time to reach highest
sensory level  of Group B is much earlier than Group A and it is
statistically significant (P value 0.003). Time to reach highest sensory level
of Group A is earlier than Group C and it is not statistically significant.
Comparison of mean time for two segment regression of sensory level
among three Groups:
N Mean Std. Deviation P value
TRSL Group A 40 90.40 13.79
<0.0001
Group B 40 81.35 6.77
Group C 40 50.98 3.58
Total 120 74.24 19.19
Tab.9.TRSL comparison
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Dependent Variable Mean Difference
(I-J)
P value
TRSL Group A Group B 9.05 0.000
Group C 39.43 0.000
Group B Group A -9.05 0.000
Group C 30.38 0.000
Group C Group A -39.43 0.000
Group B -30.38 0.000
Tab.10.TRSL multiple comparison
Chart 7: TRSL comparison
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Comparison of mean time for two segment regression of sensory
level among three groups is statistically significant (P value  <0.0001).
Mean time for two segment regression of sensory level  of Group A is
much higher than Group B and it is statistically significant (P value 0.000).
Mean time for two segment regression of sensory level of Group B is
higher than Group C and it is statistically significant (P value 0.000).
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Comparison of mean time of onset of motor block
N Mean Std. Deviation P value
MOT Group A 40 2.33 0.69
<0.0001
Group B 40 1.48 0.51
Group C 40 3.43 0.93
Total 120 2.41 1.08
Tab.11.MOT comparison
Dependent Variable Mean Difference
(I-J)
P value
MOT Group A Group B 0.85 0.000
Group C -1.10 0.000
Group B Group A -0.85 0.000
Group C -1.95 0.000
Group C Group A 1.10 0.000
Group B 1.95 0.000
Tab.12.MOT multiple comparison
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Chart 8: MOT comparison
Comparison of mean time of onset of motor block among three
groups is statistically significant (P value <0.0001). Mean time for onset
of motor block  of Group B is  earlier than Group A and it is statistically
significant (P value 0.000). Mean time for onset  of motor block of Group
A is  higher than Group C and it is  statistically significant (P value 0.000).
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Comparison of  highest sensory level reached among three Groups:
HSL
Total P value
T2 T3 T4 T5 T6
group
Group A 14 0 22 4 0 40
<0.0001Group B 2 2 20 16 0 40
Group C 0 0 1 8 31 40
Total 16 2 43 28 31 120
Tab.13.HSL comparison
Chart 9: HSL comparison
The Median Highest sensory level reached in Group A T2 level (14
patients) and the range is from (T2 to T5). The Median Highest sensory
level reached in Group B T2 level (2 patients) and the range is from (T2 to
T5). The Median Highest sensory level reached in Group C  T4 level (1
patient) and the range is from (T4 to T6). Comparison is statistically
significant (P value <0.0001).
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Chart 10: Comparison of duration of Motor block:
N Mean
Std.
Deviation P value
DMB Group A 40 3.41 .322
<0.0001Group B 40 3.19 .747Group C 40 1.97 .358
Total 120 2.86 .815
Tab .14.DMB comparison
Dependent Variable Mean Difference(I-J) P value
DMB
Group A Group B .214 .195Group C 1.439* .000
Group B Group A -.214 .195Group C 1.225* .000
Group C Group A -1.439* .000Group B -1.225* .000
Tab.15.DMB multiple comparison
Mean duration of motor block of Group A is( 3.41  .322 hrs)  higher than
Group B (3.19  .747) and Group C (1.97  .358) and  its  statistically
significant (P value 0.0001).In multiple comparison mean duration of
motor block of both Group A and B are much higher than Group C and its
statistically significant (P value 0.000).
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Comparison of duration of analgesia:
N Mean Std. Deviation P value
DOA Group A 40 5.15 .350
<0.0001
Group B 40 4.05 .539
Group C 40 2.64 .349
Total 120 4.36 4.702
Tab.16.DOA comparison
Dependent Variable Mean Difference
(I-J)
P value
DOA
Group A
Group B 1.090 .000
Group C 2.5 .000
Group B
Group A -1.090 .000
Group C 1.410 .000
Group C
Group A -2.5 .000
Group B -1.410 .000
Tab.17.DOAmultiple comparison
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Chart 11: DOA comparison
The mean time of duration of analgesia of Group A > Group B > Group C
and it is statistically significant (pvalue = < 0.0001). In multiple
comparison also its statistically significant Group A vs Group B (p value
0.000), Group A vs Group C (pvalue 0.000) and Group B vs Group C (p
value 0.000)
Comparison of side effects observed during study :
complication Total PvalueNil Bradycardia Hypotension Shivering
group
Group
A 34 3 2 1 40
0.573GroupB 34 4 2 0 40
Group
C 34 2 1 3 40
Total 102 9 4 4 120
Tab.18 Side effects comparison
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Chart 12: Side effects comparison
Side effects observed during study was very minimal and most of the cases
were stable and it is not statistically significant.
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Preoperative vitals
PREOPERATIVE
VITALS N Mean Std.Deviation P value
SBP
Group A 40 123.90 3.62
0.327Group B 40 121.40 5.15Group C 40 122.60 11.26
Total 120 122.63 7.46
DBP
Group A 40 74.80 5.02
0.530Group B 40 74.15 5.50Group C 40 73.55 4.26
Total 120 74.17 4.94
PR
Group A 40 78.67 8.06
0.428Group B 40 78.80 6.50Group C 40 77.70 5.76
Total 120 79.75 7.12
SPO2
Group A 40 99.35 4.11
0.400Group B 40 99.95 0.32Group C 40 100.00 0.00
Total 120 99.77 2.38
Table .19. Preoperative vitals
No statistically significant difference in three groups in terms of
preoperative vitals.
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Comparison of systolic blood pressure among three groups: Systolic
BP comparison
N Mean
Std.
Deviation P value
sbp0 Group A 40 118.45 4.40
0.026
Group B 40 115.50 5.97
Group C 40 117.35 3.96
Total 120 117.10 4.97
sbp3 Group A 40 114.50 4.72
0.002
Group B 40 111.30 6.97
Group C 40 115.50 4.29
Total 120 113.77 5.70
sbp6 Group A 40 109.75 6.06
0.012
Group B 40 108.35 6.55
Group C 40 112.40 5.57
Total 120 110.17 6.25
sbp9 Group A 40 106.03 7.08
0.018
Group B 40 109.25 6.62
Group C 40 110.00 5.91
Total 120 108.43 6.73
sbp12 Group A 40 108.90 7.71
0.626
Group B 40 110.38 6.14
Group C 40 109.35 6.98
Total 120 109.54 6.94
sbp15 Group A 40 110.80 7.23
0.633
Group B 40 112.20 5.41
Group C 40 111.55 6.83
Total 120 111.52 6.51
Total 120 68.29 4.76
sbp30 Group A 40 114.10 6.46
0.353
Group B 40 113.95 4.97
Group C 40 115.55 4.76
Total 120 114.53 5.45
sbp45 Group A 40 113.78 7.17
<0.0001
Group B 40 114.85 4.94
Group C 40 118.95 3.87
Total 120 115.86 5.89
Total 120 75.68 4.24
Table.20.Sbp comparison
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Multiple comparrisons:
Dependent Variable Mean Difference
(I-J)
P value
sbp0 Group A Group B 2.95 0.023
Group C 1.10 0.939
Group B Group A -2.95 0.023
Group C -1.85 0.273
Group C Group A -1.10 0.939
Group B 1.85 0.273
Table.21.SBP at 0min
Dependent Variable Mean Difference
(I-J)
P value
sbp3 Group A Group B 3.20 0.030
Group C -1.00 1.000
Group B Group A -3.20 0.030
Group C -4.20 0.002
Group C Group A 1.00 1.000
Group B 4.20 0.002
Table.22.Sbp at 3min
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Dependent Variable Mean Difference
(I-J)
P value
sbp6 Group A Group B 1.40 0.914
Group C -2.65 0.160
Group B Group A -1.40 0.914
Group C -4.05 0.010
Group C Group A 2.65 0.160
Group B 4.05 0.010
Table.23.Sbp at 6min
Dependent Variable Mean Difference
(I-J)
P value
sbp9 Group A Group B -3.22 0.089
Group C -3.98 0.023
Group B Group A 3.22 0.089
Group C -0.75 1.000
Group C Group A 3.98 0.023
Group B 0.75 1.000
Table.24.Sbp at 9min
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Dependent Variable Mean Difference
(I-J)
P value
sbp45 Group A Group B -1.07 1.000
Group C -5.18 0.000
Group B Group A 1.07 1.000
Group C -4.10 0.003
Group C Group A 5.18 0.000
Group B 4.10 0.003
Table.25.Sbp at 45min
Chart: 13 Comparison of SBP
Comparison of mean systolic blood pressure among Group A, Group B,
Group C is statistically significant at 0min,3min,6min,9min and 45min. In
multiple comparison the mean SBP of Group A is higher than Group B &
C at 0,3,6,45min. SBP of Group A is lower than Group B & C at 9min and
it is statistically significant. chart 4.
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Diastolic blood pressure
DBP Group A Group B Group C
Pre 74.80 74.15 73.55
0.00 71.45 70.30 70.55
3.00 69.10 67.80 69.65
6.00 68.50 65.18 67.90
9.00 67.55 66.25 67.45
12.00 68.95 67.40 66.55
15.00 68.63 68.35 67.90
30.00 69.40 68.35 71.45
45.00 69.50 68.85 70.65
Tab.26.DBP
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N Mean Std.Deviation P value
pre_dbp Group A 40 74.80 5.02
0.530
Group B 40 74.15 5.50
Group C 40 73.55 4.26
Total 120 74.17 4.94
dbp0 Group A 40 71.45 4.10
0.461
Group B 40 70.30 4.31
Group C 40 70.55 4.57
Total 120 70.77 4.32
dbp3 Group A 40 69.10 3.14
0.178
Group B 40 67.80 5.80
Group C 40 69.65 4.29
Total 120 68.85 4.57
dbp6 Group A 40 68.50 5.20
0.003
Group B 40 65.18 3.77
Group C 40 67.90 4.32
Total 120 67.19 4.66
dbp9 Group A 40 67.55 4.36
0.350
Group B 40 66.25 4.58
Group C 40 67.45 4.39
Total 120 67.08 4.44
dbp12 Group A 40 68.95 6.88
0.111
Group B 40 67.40 4.23
Group C 40 66.55 3.76
Total 120 67.63 5.20
dbp15 Group A 40 68.63 5.19
0.792
Group B 40 68.35 4.15
Group C 40 67.90 4.96
Total 120 68.29 4.76
dbp30 Group A 40 69.40 4.47
0.004
Group B 40 68.35 4.12
Group C 40 71.45 3.90
Total 120 69.73 4.33
dbp45 Group A 40 69.50 5.02
0.131
Group B 40 68.85 3.76
Group C 40 70.65 2.98
Total 120 69.67 4.04
Tab.27.DBP comparison
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Dependent Variable Mean Difference
(I-J)
P value
dbp6 Group A Group B 3.33 0.004
Group C 0.60 1.000
Group B Group A -3.33 0.004
Group C -2.73 0.022
Group C Group A -0.60 1.000
Group B 2.73 0.022
Tab .28. DBP at 6min
Dependent Variable Mean Difference
(I-J)
P value
dbp30 Group A Group B 1.05 0.787
Group C -2.05 0.089
Group B Group A -1.05 0.787
Group C -3.10 0.004
Group C Group A 2.05 0.089
Group B 3.10 0.004
Tab.29.DBP at 30min
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Chart: 14 DBP comparison
Comparing the mean diastolic BP of three groups is statistically
significant at 6min and 30min. In multiple comparison, Mean Diastolic Bp
at 6min  of Group A  is higher than Group B(statistically significant) &
also Group C is higher than Group B( statistically significant). Mean
Diastolic Bp  at 30min  of Group A  is higher than Group C (statistically
significant) & also Group C is higher than Group B
(statistically significant).
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N Mean Std. Deviation P value
pre_pr Group A 40 78.67 8.06 0.428
Group B 40 78.80 6.50
Group C 40 77.70 5.76
Total 120 79.75 7.12
pr0 Group A 40 77.90 7.84 0.136
Group B 40 75.40 8.55
Group C 40 74.63 6.20
Total 120 75.98 7.66
pr3 Group A 40 74.85 6.84 0.063
Group B 40 72.28 8.63
Group C 40 71.33 4.48
Total 120 72.82 6.97
pr6 Group A 40 73.73 8.45 0.016
Group B 40 69.55 10.60
Group C 40 68.65 4.67
Total 120 70.64 8.50
pr9 Group A 40 71.80 8.99 0.403
Group B 40 70.20 88.42
Group C 40 67.80 3.70
Total 120 74.13 51.32
pr12 Group A 40 72.60 7.29 0.002
Group B 40 67.95 6.21
Group C 40 69.35 3.83
Total 120 69.97 6.22
pr15 Group A 40 73.10 6.39 0.202
Group B 40 70.85 5.82
Group C 40 72.00 4.37
Total 120 71.98 5.62
pr30 Group A 40 73.63 4.90 0.507
Group B 40 72.55 5.06
Group C 40 73.55 3.69
Total 120 73.24 4.58
pr45 Group A 40 75.40 4.92 0.153
Group B 40 73.60 4.30
Group C 40 73.95 3.80
Total 120 74.32 4.40
Tab.30.PR comparison
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Dependent Variable Mean Difference
(I-J)
P value
pr6 Group A Group B 4.18 0.078
Group C 5.08 0.021
Group B Group A -4.18 0.078
Group C 0.90 1.000
Group C Group A -5.08 0.021
Group B -0.90 1.000
Tab 31.PR at 6min
Dependent Variable Mean Difference
(I-J)
P value
pr12 Group A Group B 4.65 0.002
Group C 3.25 0.049
Group B Group A -4.65 0.002
Group C -1.40 0.886
Group C Group A -3.25 0.049
Group B 1.40 0.886
Table.32.PR at 12min
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Chart: 15 Comparison of pulse rate
Comparison of pulse rate between three groups at 6min and 12min are
statistically significant. Mean pulse rate  of Group A at 6min 73/min, at
12min 72/min ,Group  B at 6min 69/min,at12min 67/min, and  Group C at
6min 68/min, at 12min 69/min.
Spo2 Mean
Group A Group B Group C
Pre 99.35 99.95 100.00
spo0 100.00 99.35 100.00
spo3 100.00 99.95 100.00
spo6 100.00 99.93 100.00
spo9 100.00 99.93 100.00
spo12 100.00 99.90 100.00
spo15 100.00 99.90 100.00
spo30 100.00 99.90 100.00
spo45 100.00 100.00 100.00
Table.33.Spo2 comparison
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Chart: 16 Comparison of  Spo2
Statistically no significance in the comparison of  mean Spo2 among three
groups.
Postoperative vitals comparison:
N Mean Std. Deviation P value
postop_sbp 0.012
Group B 40 117.23 5.12
Group C 40 121.50 3.53
Total 120 118.56 7.78
postop_dbp Group A 40 69.25 3.67 0.047
Group B 40 69.30 3.75
Group C 40 70.95 2.86
Total 120 69.83 3.51
postop_hr Group A 40 74.80 4.39 0.070
Group B 40 75.35 3.96
Group C 40 76.90 4.17
Total 120 75.68 4.24
postop_spo2 Group A 40 100.00 0.00 n/a
Group B 40 100.00 0.00
Group C 40 100.00 0.00
Total 120 100.00 0.00
Table.34.Post operative vitals comparison
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Dependent Variable Mean Difference
(I-J)
P value
postop_sbp
Group A Group B -0.27 1.000
Group C -4.55 0.024
Group B Group A 0.27 1.000
Group C -4.28 0.038
Group C Group A 4.55 0.024
Group B 4.28 0.038
postop_dbp
Group A Group B -0.05 1.000
Group C -1.70 0.089
Group B Group A 0.05 1.000
Group C -1.65 0.104
Group C Group A 1.70 0.089
Group B 1.65 0.104
postop_hr Group A Group B -0.55 1.000
Group C -2.10 0.079
Group B Group A 0.55 1.000
Group C -1.55 0.299
Group C Group A 2.10 0.079
Group B 1.55 0.299
Tab.35.Postop vitals multiple comparison
Comparing the postoperative vitals among the three groups, the systolic
and diastolic Bp are statistically significant with p value 0.012 & 0.047
respectively. PR, spo2 are not statistically significant.
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DISCUSSION
Extensive research have been done over the years mainly to
improve the quality of spinal anaesthesia simply by varying drug regimens
and technical methods. Normally  to prolong the anaesthetic effects
adjuvants are added to hyperbaric bupivacaine 0.5% and given
intrathecally. Adjuvants produce antinociceptive effect by acting
perineurally or by acting  at different receptor sites in the spinal cord.
Adjuvants mainly opioids  are capable of producing early onset of
sensory and motor blockade and also prolongs the postoperative analgesia.
They also have sympathetic and motor sparing activities which allows
early ambulation of patients postoperatively.
Nalbuphine hydrochloride is a mixed μ antagonist and κ agonist
opioid. Nalbuphine has been found to cause prolongation of the effects of
local anaesthetics in intrathecal, epidural and also in peripheral nerve
blocks and it has the advantages of minimal respiratory depression and
better hemodynamic stability.
Various studies had been done using 25mcg of fentanyl added to
0.5% hyperbaric bupivacaine which administered intraathecally for
various surgeries, including gynaecological surgeries/lower limb
surgeries/lower abdominal surgeries/caesarean section  and revealed the
efficacy and safety of intrathecal fentanyl.
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Intrathecal fentanyl and nalbuphine hydrochloride was in practice
over many years and found to be safe and effective and has no neurotoxic
side effects when used intrathecally.
Mukherjee et al performed a study to determine whether Nalbuphine
hydrochloride is safe and whether it helps to prolongs analgesia by
comparing it with control group and also to determine the optimum dose
of intrathecal nalbuphine'. They  observed that 0.4mg of nalbuphine +
0.5% hyperbaric bupivacaine prolongs the duration of postoperative
analgesia without any side effects. Hence we used 0.5mg of nalbuphine
intrathecally.
Sensory blockade:
In my study, fentanyl significantly shortens the time of onset of
sensory block when to compared to nalbuphine. The mean onset time of
sensory block (T10) in the nalbuphine group was found to be 3.05±0.88
mins, in fentanyl  group it is 2.25±0.63 mins ,whereas in the control group
it was found to be 4.08±1.25 mins. In Fentanyl group the mean time of
onset of sensory block was 0.80mins earlier than nalbuphine group.
Comparison of  mean time to reach highest sensory level among three
Groups is statistically significant (P value0.002). Time to reach highest
sensory level  of  Fentanyl group was (11.68±2.44 mins) much earlier than
nalbuphine Group (13.75±2.06 mins) and it is statistically significant (P
value 0.003).Early onset and earlier to reach highest sensory level of
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blockade by fentanyl group may be explained due to high lipid solubility
of fentanyl which makes it to cross blood brain barrier easily and also rapid
tissue uptake. Similar result was obtained by the study conducted by
Gurunath BB et al., (39) in 2018 and study conducted by Ravikiran J Thote
et al., (33) However the study conducted by Hala Mostafa Gomaa et al., (36)
concluded that there is no significant difference between intrathecal
nalbuphine and fentanyl regarding to the sensory blockade.
More number of patients in the nalbuphine group (A) achieved
higher sensory level (T2 toT4) than the patients in the fentanyl   Group(B)
(T2 to T5). The mean time for two sement regression of sensory block in
the nalbuphine group was found to be 90.40±13.79 mins and in fentanyl
group B was 81.35±6.77 mins whereas in the control group it was found to
be 50.98±3.58 mins. Higher sensory level and more prolongation of two
segment regression of sensory blockade by intrathecal nalbuphine than
intrathecal fentanyl was concluded by  the studies conducted by Ravikiran
J Thote et al., (33) Gurunath BB et al., (39 ) , Shehla Shakooh et al (30), and
by Jyothi B et al., (30).
Motor blockade:
The mean onset time of motor block was found to be 2.33±0.69
mins in the nalbuphine group, 1.48±0.51 mins whereas in the control group
it was found to be 3.43±0.93 mins. Similar to sensory blockade the onset
of motor blockade is much earlier in fentanyl group than nalbuphine group
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just because of highly  liphophillic nature of fentanyl. Mean duration of
motor blockade in the nalbuphine group was 3.41±0.322 hrs, in the
fentanyl group it is3.19±0.747hrs and in the control group was 1.97±0.358
hrs which was  statistically significant( p value <0.0001). Mean duration of
motor blockade in nalbuphine group is higher than fentanyl group.
Study conducted by Ravikiran J Thote et al., (33) , and the study
conducted by Pallavi Ahluwalia et al., (37) concludes similar results.
However Hala Mostafa Gomaa et al., (36) concludes that there is no
statistically significant difference in the duration of motor blockade
between intrathecal nalbuphine and fentanyl.
Duration of analgesia:
The mean duration of analgesia in the nalbuphine group was found
to be 5.15±.350 hrs , in fentanyl group was 4.05±.539hrs and in the
control group it was found to be 2.64±0.349hrs which was statistically
significant (p value <0.0001) between the three groups. The results that
obtained in our study reveals that duration of analgesia is much prolonged
by intrathecal nalbuphine than fentanyl.
Study conducted  by Ravikiran J Thote et al., (33) also
concludes that intrathecal  nalbuphine prolongs the duration of analgesia
than intrathecal fentanyl. Shehla shakooh,et al., (33) study also concludes
that sensory blockade ,motor blockade and post operative analgesia was
much prolonged with intrathecal nalbuphine group than plain bupivacaine
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group. Mukherjee et al., (33)2011 study concluded that 0.4mg nalbuphine is
the most effective intrathecal dose that increases postopertative analgesia
with no  side sffects. Gurunath BB et al., (39) Study also cocludes that the
nalbuphine group had much prolonged duration of postoperative analgesia
than fentanyl group.
Haemodynamic parameters:
Comparison of mean systolic blood pressure among  Group A,
Group B, Group C is statistically significant at
0min(p<0.026),3min(p<0.002), 6min(P<0.012), 9min (p<0.018) and
45min(p<0.0001). In multiple comparison the mean SBP of nalbuphine
Group A is higher than fentanyl Group B & control group C at 0,3,6,45
min. SBP of Group A is lower than Group B & C at 9min and it is
statistically significant(p<0.018). Comparing the mean diastolic BP of
three groups is statistically significant at 6min (p<0.003) and 30min
(p<0.004). In multiple comparison, Mean Diastolic Bp  at 6min  of Group
A  is higher than Group B which is statistically significant(p <0.004)  and
also Group C is higher than Group B which is statistically significant(p
<0.022). Mean Diastolic Bp  at 30min  of Group A  is higher than Group C
(not statistically significant) & also Group C is higher than Group B (
statistically significant p<0.004 ). Comparison of pulse rate between three
groups at 6min (p<0.016) and 12min (p<0.002) are statistically significant.
Mean pulse rate  of Group A at 6min 73/min, at 12min 72/min ,Group  B at
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6min 69/min,at12min 67/min, and  Group C at 6min 68/min, at 12min
69/min.
Comparing the postoperative vitals among the three groups, the
systolic and diastolic Bp are statistically significant with p value< 0.012 &
< 0.047 respectively. PR, spo2 are not statistically significant. Though
statistically significant variation was noted in haemodynamic parameters
like non invasive blood pressure(NIBP)/HR/spo2  periodically both
intraoperative and postoperative period among the three groups, all
patients were haemodynamically stable in all three groups. Intrathecal
opioids  intensifies the sensory block without increasing sympathetic block
just because they are synergistic with local anaesthetics. Our results are
similar to the results concluded by Hala Mostafa Gomaa et al study., (36)
Side effects:
Bradycardia and hypotension observed was treatable and it was
mainly due to the sympathetic blockade of the local anaesthestics  itself
and not by the adjuvants added. Shivering was observed more in control
group than the nalbuphine  group. Side effects observed during our study
was very minimal and most of the cases were stable and it is not
statistically significant. Various studies conducted concludes the safety and
effectiveness of nalbuphine and fentanyl when added  intrathecaliy.
94
SUMMARY
A double blinded randomized controlled study was conducted in
120 patients belonging to ASA I and II undergoing elective hernioplasty
surgeries to compare Nalbuphine  and Fentanyl given intrathecally with
hyperbaric 0.5% bupivacaine for perioperative anaesthesia /postoperative
analgesia.
Patients were divided randomly into three groups of 40 each.
Group A received 3 ml 0.5% bupivacaine (15 mg) and 0.5 ml of
nalbuphine (0.5 mg).
Group B received 3 ml 0.5% bupivacaine (15 mg) and 0.5 ml
fentanyl(25 mcg).
Group C received 3 ml 0.5% bupivacaine (15 mg) and 0.5 ml normal
saline.
Equal  volume of the solution was injected, 3.5 ml in all the three
groups.
Sensory blockade and motor blockade onset time, time to reach
maximum sensory level, two segment regression time, the duration of
sensory and motor blockade and the duration of analgesia were noted in all
the three groups.
Demographic data obtained were similar in all the three groups.
We found that the onset of sensory and motor blockade, time to
reach highest sensory level blockade was earlier in the Group B (fentanyl)
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than the Nalbuphine Group A. More number of patients to reach highest
sensory level blockade was with the Nalbuphine Group A than the Group
B (fentanyl) The duration of motor blockade, two segment regression of
sensory block, and duration of analgesia was prolonged in the Nalbuphine
group than Fentanyl group.
Side effects observed during study was very minimal and most of
the cases were stable in all the three groups.
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CONCLUSION
Comparing between Intrathecal Nalbuphine and Fentanyl concludes
that: Intrathecal Nalbuphine may be a good alternative to Fentanyl in
surgeries like hernioplasty and in below umbilical surgeries which
provides a prolonged sensory and motor blockade, and prolonged duration
of analgesia without any adverse effects.
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PATIENT CONSENT FORM
STUDY TITLE
Comparison of Intrathecal  Nalbuphine  vs Fentanyl added to 0.5%
Hyperbaric Bupivacaine for perioperative anaesthesia  and
perioperative/postoperative analgesia in Hernioplasty.
STUDY CENTRE
TIRUNELVELI MEDICAL COLLEGE AND HOSPITAL,
TIRUNELVELI.
PARTICIPANT NAME :
AGE                                  :
SEX                                  :
I confirm that I have understood the purpose of procedure for the
above study . I have the opportunity to ask the question and all my
questions and doubts have been answered to my satisfaction. I have been
explained about the pitfalls in the procedure. I have been explained about the
safety, advantage and disadvantage of the technique.
I understand that my participation in the study is voluntary and that I am
free to withdraw at anytime without giving any reason. I understand that
investigator, regulatory authorities and the ethics committee will not need my
permission to look at my health records both in respect to current study and any
further research that may be conducted   in relation to it, even if I withdraw from
the study .
I understand that my identity will not be revealed in any
information released to third parties or published , unless as required under the
law. I agree not to restrict the use of any data or results that arise from the study.
I understood that I will receive drugs to prolong the duration of analgesia using
nalbuphine in subarachnoid block. I have been explained that the anesthetic
technique is a standard and approved technique. This may help in future research
in the field of anesthesia. I consent to undergo this procedure.
INSURANCE NO:
DATE:
Signature / thumb impression of patient
KEY TO MASTER CHART
GROUPS
GROUP A = Bupivacaine + Nalbuphine
GROUP B = Bupivacaine + Fentanyl
GROUP C = Bupivacaine + Normal Saline
PARAMETERS
SOT   =  sensory block onset time
THSL =time to reach  highest sensory block level
TRSL = time for two segment regression of sensory block level
MOT  = time of  onset of  motor block
DMB  = duration of motor block
DOA  = duration of analgesia
PR      = pulse rate
SBP    = systolic blood pressure
DPB    = diastolic blood pressure
PROFORMA
COMPARISON OF INTRATHECAL NALBUPHINE VS FENTANYL ADDED TO
0.5% HYPERBARIC BUPIVACAINE FOR PERIOPERATIVE ANAESTHESIA AND
PERIOPERATIVE / POST OPERATIVE ANALGESIA IN HERNIOPLASTY
Name: Age: ASA PS:
Height: Weight:
Group:
Drug used in SAB:
Pre operative:
BP
PR
SPO2
Intra Operative
Immediately 3 min 6 min 9 min 12 min 15 min 30 min 45 min Post op
BP
PR
SPO2
Onset of Sensory Block:
Highest Level of Sensory Block :
Time taken to Reach Highest Level of Sensory Block:
Two Segment Regression of Sensory Level:
Onset of Motor Block:
Duration of Motor Block:
Side Effects:
Duration of Analgesia :
NehahspfSf;F mwptpg;G kw;Wk; xg;Gjy; gbtk; 
(kUj;Jt Ma;tpy; gq;Nfw;gj;w;F) 
Ma;T nra;ag;gLk; jiyg;G:  
gq;F ngWthpd; ngaH: 
gq;F ngWthpd; taJ: 
  gq;F ngWth; 
,jid  
Fwpf;fTk; 
1.  ehd; NkNy Fwpg;gpl;Ls;s kUj;Jt Ma;tpd; tptuq;fis gbj;J 
Ghpe;J nfhz;Nld;. vd;Dila re;Njfq;fis Nfl;fTk;> 
mjw;fhd jFe;j tpsf;fq;fis ngwTk; tha;g;gspf;fg;gl;Ls;sJ 
vd mwpe;J nfhz;Nld;. 
 
2.  ehd; ,t;tha;tpy; jd;dpr;irahf jhd; gq;Nfw;fpNwd;. ve;j 
fhuzj;jpdhNyh ve;j fl;lj;jpYk;> ve;j rl;l rpf;fYf;Fk; 
cl;glhky; ehd; ,t;tha;tpy; ,Ue;J tpyfp nfhs;syhk; vd;Wk; 
mwpe;J nfhz;Nld;. 
 
3.  ,e;j Ma;T rk;ge;jkhfNth> ,ij rhHe;J NkYk; Ma;T 
Nkw;fhs;Sk; NghJk; ,e;j Ma;tpy; gq;FngWk; kUj;JtH 
vd;Dila kUj;Jt mwpf;iffis ghHg;gjw;F vd; mDkjp 
Njitapy;iy vd mwpe;J nfhs;fpNwd;. ehd; Ma;tpy; ,Ue;J 
tpyfpf; nfhz;lhYk; ,J nghUe;Jk;; vd mwpfpNwd;. 
 
4.  ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah> KbitNah 
gad;gLj;jpf; nfhs;s kWf;f khl;Nld;. 
 
5.  ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd; vdf;F 
nfhLf;fg;gl;lmwpTiufspd; gb ele;J nfhs;tJld;> Ma;it 
Nkw;nfhs;Sk; kUj;Jt mzpf;F cz;ikAld; ,Ug;Ngd; vd;W 
cWjpaspf;fpNwd;. vd; cly; eyk; ghjpf;fg;gl;lhNyh> my;yJ 
vjpHghuhj> tof;fj;jpw;F khwhd Neha;Fwp njd;gl;lhNyh clNd 
,ij kUj;Jt mzpaplk; njhptpg;Ngd; vd cWjp mspf;Nwd;. 
 
 
gq;Nfw;gthpd; ifnahg;gk; / .................................................... ,lk; ........................................... 
fl;iltpuy; Nuif 
gq;Nfw;gthpd; ngaH kw;Wk; tpyhrk; ........................................................................................ 
Ma;thshpd; ifnahg;gk; /...................................................... ,lk; ............................................ 
Ma;thshpd; ngaH ......................................................................................................................... 
ikak; ...............................................................................................................................................  
fy;tpawpT ,y;yhjtw;F (ifNuif itj;jtHfSf;F) ,J mtrpak; Njit 
rhl;rpapd; ifnahg;gk; /...................................................... ,lk; ................................................ 
ngaH kw;Wk; tpyhrk; ................. ................................................................................................... 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP
1 Malaiselvam 26 M A 164 60 I 120 68 72 100 110 70 112 68 108 64 102 68 112 64 108 66 104 66 112 68
2 Udhayakumar 27 M A 168 72 I 118 70 74 100 112 68 110 66 104 66 102 68 112 70 110 74 108 70 116 72
3 Madasamy 56 M A 170 70 II 120 74 80 100 114 70 114 68 108 62 100 60 106 64 112 68 116 74 114 68
4 Anantha Kumar 56 M A 168 69 II 126 82 86 100 120 74 118 70 116 84 108 66 104 62 100 68 110 70 116 74
5 Marimuthu 47 M A 162 64 II 124 84 90 100 122 78 116 72 114 80 100 74 108 72 118 74 116 70 120 66
6 Shanmuganathan 47 M A 166 64 II 120 80 94 100 120 80 110 70 110 70 100 70 110 70 120 76 120 74 126 80
7 Arunachalam 51 M A 168 67 II 122 74 84 100 118 70 116 66 104 64 100 66 102 68 112 66 118 68 118 70
8 Velu 28 M A 170 72 I 124 76 86 100 120 72 118 68 106 66 96 68 98 70 116 72 116 70 118 74
9 Esakki 54 M A 162 64 II 126 78 88 100 122 74 120 70 108 68 98 70 100 72 118 74 118 72 120 76
10 Subbiah 56 M A 165 61 II 128 80 90 100 124 76 118 72 110 70 100 72 110 74 120 76 120 74 122 78
11 Udhayakumar 37 M A 167 71 I 124 76 84 100 120 68 110 74 104 68 102 62 102 66 110 70 112 72 108 68
12 Shamugam 50 M A 166 68 II 124 74 78 100 122 68 124 66 118 66 114 64 116 68 108 64 116 68 104 64
13 Ram 39 M A 165 65 I 122 72 76 100 120 70 122 68 118 64 112 62 114 68 108 62 114 66 102 60
14 Arumugam 22 M A 164 64 I 130 80 78 100 130 60 130 62 130 62 128 58 134 54 134 58 132 62 136 66
15 Sankara Narayanan 54 M A 160 58 II 130 90 90 100 128 80 112 70 108 70 113 66 112 60 116 65 119 70 115 70
16 Selvaraj 48 M A 162 60 II 126 72 90 100 122 70 118 68 110 68 112 70 106 74 112 66 118 68 112 70
17 Arudaiappan 50 M A 164 63 II 124 78 86 100 120 68 112 64 108 66 108 68 104 70 110 68 118 66 120 66
18 Arunachalam 28 M A 169 67 I 122 72 74 100 118 64 112 76 106 64 104 60 106 68 110 66 114 70 108 70
19 Mohaned Hajun 52 M A 167 65 II 128 76 92 100 118 70 108 72 102 64 100 64 104 68 108 66 110 68 104 62
20 Sudalimuthu 35 M A 168 74 I 128 78 92 100 118 72 110 66 98 64 94 66 88 62 108 66 112 68 110 70
21 Sundarraj 48 M A 163 62 II 116 78 88 100 116 72 112 70 110 70 104 68 110 70 112 72 114 74 118 72
22 Thangadurai 56 M A 164 62 II 118 80 90 100 118 74 110 72 112 74 102 70 112 72 110 74 118 76 120 74
23 Chelliah 55 M A 166 60 II 126 74 86 100 112 74 114 70 110 66 104 70 114 66 110 68 106 68 114 70
24 Kalimuthu 23 M A 164 60 I 124 70 80 100 110 72 112 68 110 66 106 72 112 64 108 66 104 64 112 64
25 Shanmujaiah 54 M A 168 70 II 128 78 96 100 116 68 110 66 100 62 96 68 98 60 98 62 100 60 106 64
26 Kannan 32 M A 164 66 I 130 80 98 100 114 66 108 64 98 60 94 64 96 96 98 58 95 56 100 60
27 Arumugam 39 M A 168 64 I 122 72 68 100 122 68 120 68 116 70 114 62 114 64 108 64 110 68 104 64
28 Kalimuthu 22 M A 164 62 I 120 70 66 100 124 70 120 68 118 68 112 60 112 64 108 62 114 66 102 60
29 Kannan 45 M A 166 62 II 122 70 84 100 120 68 118 64 112 70 116 70 110 68 112 66 114 80 118 76
30 Chellaiah 46 M A 164 62 II 126 70 72 100 118 68 112 70 108 68 104 64 100 60 88 62 108 68 110 70
31 Petchimuthu 45 M A 172 70 I 128 74 78 100 120 74 118 76 116 78 114 76 116 78 116 78 122 74 116 76
32 Madasamy 45 M A 170 68 I 126 72 76 100 118 72 116 74 114 76 112 74 114 76 114 76 120 72 114 74
33 Sankara Narayanan 54 M A 156 52 II 124 70 74 100 116 74 114 72 112 74 110 72 112 74 112 74 118 70 112 72
34 Chellapandi 49 M A 158 56 II 122 66 72 100 114 72 112 70 110 72 108 70 114 76 110 72 116 74 110 68
35 Kannan 46 M A 160 58 II 124 68 74 74 116 74 114 70 110 74 112 72 116 78 112 74 118 76 112 70
36 Chandran 37 M A 164 60 I 122 68 76 100 118 74 112 68 114 66 108 70 110 68 118 70 114 66 110 74
37 Saravanan 44 M A 168 64 I 118 72 84 100 114 72 110 68 112 64 108 72 116 74 108 72 116 70 120 70
38 Lakshmanan 54 M A 158 54 II 120 78 90 100 116 78 112 70 108 70 112 72 106 70 114 72 118 70 120 66
Intra Operative
6 Min 9 Min 12 Min 15 Min
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BP mmHg
Pre Operative
0 Min 3 Min 45 Min
SPO2
%
PR per
minDBP
BP mmHg
39 Sankaranarayanan 52 M A 164 60 II 126 76 88 100 114 76 110 70 106 74 110 68 108 66 106 64 112 68 114 68
40 Nallasamy 56 M A 167 69 II 128 72 86 100 124 70 116 70 104 68 102 66 118 70 112 74 116 70 118 76
41 Ulaganathan 43 M B 162 59 II 126 70 76 100 120 72 118 70 116 68 114 70 120 68 118 70 118 64 110 68
42 Chelliah 40 M B 167 68 I 126 70 74 100 120 72 118 68 108 64 110 70 112 68 116 72 118 70 120 72
43 Muthupandi 50 M B 163 65 I 126 78 86 100 122 70 118 70 116 68 104 62 100 64 110 66 112 68 118 72
44 Kasthurirengan 56 M B 162 64 II 126 76 90 100 120 72 118 64 108 66 114 66 106 68 100 70 112 72 118 74
45 Sanmuganathan 47 M B 160 61 I 122 68 78 100 120 64 110 60 108 60 104 62 100 62 114 68 112 66 116 66
46 Sudalaimani 34 M B 166 63 I 124 70 80 100 120 68 118 64 112 60 116 64 118 60 112 66 110 68 114 68
47 Sankaralingam 50 M B 162 64 II 116 74 78 100 112 70 114 68 102 66 108 68 112 68 118 70 114 66 110 70
48 Jankishan 42 M B 168 69 II 126 70 82 100 124 72 110 70 108 66 112 68 110 68 112 70 114 72 120 68
49 Umarkanth 52 M B 169 70 II 124 74 78 100 122 70 124 80 124 68 120 66 118 76 118 74 116 70 118 70
50 Chandrasekaran 54 M B 167 64 II 120 76 76 100 118 72 116 70 110 70 108 66 100 60 102 62 110 70 108 68
51 Kangaraj 45 M B 162 66 I 118 72 70 100 114 70 112 68 110 68 114 60 108 62 110 68 112 66 118 64
52 Chandran 39 M B 170 74 I 128 76 80 98 130 78 128 84 120 70 120 68 118 78 120 76 112 66 108 58
53 Nambi 54 M B 166 69 I 112 74 84 100 108 70 102 64 100 60 106 64 110 68 108 66 106 68 110 70
54 Manikandan 60 M B 160 59 I 116 70 78 100 110 68 108 66 104 68 106 66 110 70 104 64 108 66 112 70
55 Muniyandi 42 M B 162 64 II 110 68 70 100 106 62 104 60 108 62 110 68 112 64 106 60 110 70 112 68
56 Murugan 42 M B 164 66 I 126 70 74 100 112 64 106 62 110 64 114 68 114 70 116 66 118 68 114 70
57 Shekmydeen 55 M B 165 66 II 128 72 70 100 118 70 108 72 100 60 102 62 108 68 110 70 114 72 106 74
58 Alla Pitchai 52 M B 169 72 I 120 76 78 100 108 74 102 70 106 68 104 70 110 68 116 74 120 70 118 72
59 Ramalingam 50 M B 164 68 I 122 72 70 100 120 68 116 64 114 68 116 64 118 68 114 64 116 68 120 66
60 Mankain 37 M B 166 69 I 112 74 76 100 106 68 104 64 108 68 100 60 104 62 108 70 112 68 114 70
61 Karuppasamy 50 M B 169 70 II 126 78 80 100 112 66 108 64 102 62 104 68 114 70 112 70 118 68 108 70
62 Muthukrishnan 50 M B 170 74 I 118 74 76 100 108 66 110 68 104 60 112 66 114 72 118 62 116 68 118 70
63 Murugan 32 M B 168 69 II 112 70 70 100 106 72 108 70 102 64 104 66 110 68 112 66 114 68 120 66
64 Masanam 56 M B 162 65 I 126 72 78 100 108 70 100 68 104 60 110 68 112 68 118 70 120 68 122 66
65 Kaji Abdulsamak 35 M B 168 69 II 120 74 80 100 116 72 112 70 108 68 114 64 106 68 118 70 120 68 116 70
66 Gandhumathinathan 60 M B 166 68 II 120 80 100 100 110 80 98 60 108 59 100 62 95 62 100 60 96 58 106 64
67 Raja 27 M B 162 64 II 120 90 78 100 120 80 110 70 98 70 100 80 108 70 110 70 112 76 116 64
68 Madasamy 39 M B 163 65 I 126 70 78 100 110 70 104 56 104 58 106 60 118 64 112 70 114 70 114 76
69 Somu 54 M B 168 70 II 126 70 80 100 118 64 110 66 106 68 108 68 112 70 114 68 118 70 120 68
70 Ganesan 50 M B 169 72 II 124 68 78 100 118 68 112 60 114 72 116 68 114 66 108 70 112 72 118 76
71 Baseer Mydeen 22 M B 170 68 I 120 74 76 100 120 68 114 62 116 66 116 62 108 60 104 62 108 64 106 62
72 Qudrakumar 45 M B 160 62 II 118 72 74 100 114 70 108 76 102 62 100 60 106 62 116 66 118 70 120 68
73 Sheik Thervath 38 M B 166 68 I 126 76 70 100 120 70 118 72 108 64 100 62 102 68 108 70 110 60 114 66
74 Chellamuthu 42 M B 164 66 I 124 78 88 100 112 68 110 64 108 60 110 60 112 66 118 62 114 64 116 68
75 Sathyaraj 30 M B 165 67 I 120 90 94 100 120 70 122 68 120 66 126 68 124 68 120 70 126 76 124 70
76 Xavier 45 M B 166 68 I 128 70 86 100 118 76 112 74 108 66 110 70 106 68 112 76 116 78 112 74
77 Vijaya Ragavan 54 M B 167 69 II 110 70 84 100 110 64 106 66 102 64 108 70 110 72 112 68 114 70 118 72
78 Kannan 48 M B 156 60 II 120 90 78 100 120 80 110 70 98 70 100 80 108 70 110 70 112 58 106 64
79 Subbiah 54 M B 169 72 I 120 76 78 100 108 74 102 70 106 68 104 70 110 68 116 74 120 70 118 72
80 Thomas 58 M B 169 70 II 124 74 78 100 122 70 124 80 124 68 120 66 118 76 118 74 116 70 118 70
81 Jebamani 58 M C 164 66 II 126 80 68 100 124 78 120 70 122 74 120 70 118 70 124 72 120 72 122 74
82 Chellaiah 52 M C 165 66 II 128 86 86 100 122 70 120 74 124 70 118 68 110 64 116 70 120 72 122 70
83 Mayandi 28 M C 170 74 I 124 80 80 100 120 80 118 76 110 70 112 74 118 68 120 70 116 74 120 74
84 Sundarali 21 M C 167 70 I 130 90 90 100 126 84 120 80 122 80 120 74 126 70 124 72 126 76 128 70
85 Sudalaikumar 55 M C 163 60 II 120 74 72 100 116 74 114 68 116 64 108 62 110 66 108 64 110 72 118 70
86 Thangaraj 53 M C 162 59 II 122 76 74 100 118 76 116 70 118 66 110 64 112 68 110 66 112 74 120 72
87 Murugan 56 M C 166 65 II 118 72 70 100 118 64 116 60 114 62 110 60 112 64 110 68 106 62 110 70
88 Nagarajan 21 M C 165 66 I 120 70 72 100 112 66 114 62 108 66 110 64 114 68 112 70 118 70 120 72
89 Maheshkumar 40 M C 166 65 I 118 72 68 100 116 64 114 66 110 62 112 70 108 64 88 62 108 70 118 76
90 Madasamy 36 M C 169 71 II 116 70 68 100 114 64 112 64 110 60 112 66 108 60 116 70 118 72 120 70
91 Ajith 20 M C 166 70 I 120 72 76 100 118 70 116 66 110 64 112 64 114 60 116 66 120 70 120 72
92 Aathimoolam 29 M C 167 65 I 120 72 72 100 118 70 116 68 110 66 112 68 114 66 118 70 116 74 120 70
93 Mayandi 28 M C 170 68 I 120 72 72 100 120 64 118 66 110 64 112 70 86 62 110 70 112 74 114 70
94 Pattamuthu 56 M C 162 64 II 124 70 86 100 116 68 106 72 100 68 102 64 106 62 112 64 118 72 120 74
95 Krishnan 48 M C 162 58 II 124 72 76 100 120 70 120 68 114 64 110 64 108 60 112 60 114 66 118 70
96 Permnath 22 M C 160 62 I 110 70 76 100 108 64 104 60 100 60 102 64 112 68 110 70 118 70 116 74
97 Kumar 50 M C 165 67 II 124 76 78 100 120 70 118 72 108 68 110 64 100 66 104 68 118 70 120 70
98 Mariappan 54 M C 162 64 II 120 72 74 100 118 70 116 68 114 64 112 66 108 70 110 64 116 68 120 76
99 Shaumugavel 52 M C 166 62 II 120 76 80 100 118 70 116 72 114 70 114 72 108 74 104 66 118 68 120 66
100 Ganesan 52 M C 160 64 II 120 72 82 100 114 72 112 68 110 70 110 72 106 68 102 62 108 76 118 66
101 Shanmugavel 47 M C 168 66 I 124 76 86 100 118 76 116 72 114 74 114 76 110 72 106 66 112 80 122 70
102 Areumuganainar 55 M C 166 64 II 188 70 70 100 116 68 114 64 108 62 110 60 112 62 114 60 118 72 120 70
103 Mohammed Fager 22 M C 166 64 I 120 72 84 100 118 66 120 70 108 68 110 68 114 70 118 72 120 70 124 68
104 Abdul Rahaf 44 M C 164 66 I 120 70 72 100 118 70 116 66 110 64 112 62 114 64 120 74 122 76 120 74
105 Gopal 50 M C 166 62 II 120 72 74 100 118 70 116 66 110 64 112 62 114 64 116 62 120 74 124 70
106 Mariappan 40 M C 164 62 I 124 70 76 100 120 74 118 74 120 70 114 68 118 72 120 74 124 72 122 74
107 Prabhakaran 30 M C 160 63 I 120 72 78 100 118 70 116 70 120 72 110 68 112 66 110 70 114 72 118 70
108 Usmail 56 M C 164 66 II 124 74 80 100 122 70 120 74 118 70 116 72 118 74 114 68 120 70 122 76
109 Subramanian 50 M C 158 62 II 120 72 78 100 118 64 116 68 110 70 116 72 120 70 118 72 108 74 112 76
110 Nambi 54 M C 162 64 II 118 76 82 100 110 70 112 72 110 72 108 68 104 68 116 74 118 78 120 70
111 Avadiappan 54 M C 170 74 II 120 72 80 100 118 70 118 74 116 70 108 72 104 68 110 76 112 70 120 66
112 Swamydas 46 M C 164 66 I 118 70 78 100 116 68 116 72 114 68 106 70 102 66 108 74 110 68 118 64
113 Victoraj 27 M C 164 62 I 122 74 82 100 120 72 120 76 118 72 110 74 106 70 112 78 114 72 112 68
114 Gandhirajan 44 M C 160 58 II 120 72 80 100 118 70 118 74 118 70 110 70 104 68 110 74 110 70 120 66
115 Shanmugavel 55 M C 162 64 II 122 74 84 100 116 74 114 70 112 72 112 74 108 70 104 64 110 78 120 68
116 Samsudheen 50 M C 156 58 II 120 70 88 100 118 70 116 72 116 70 110 68 108 64 100 60 118 74 120 70
117 Arumugam 54 M C 158 60 I 124 74 80 100 120 70 118 70 108 72 100 64 102 66 112 62 118 66 120 70
118 Sudalai 27 M C 168 70 I 110 76 76 100 106 74 100 70 102 68 86 60 100 64 106 70 110 72 112 70
119 Raja 32 M C 164 62 I 122 72 84 100 120 70 118 72 112 64 108 66 104 60 110 60 114 62 108 70
120 Santhanaraj 35 M C 158 62 I 124 70 76 100 110 78 112 70 108 72 100 64 102 66 112 62 118 66 120 70
68 64 70 66 72 74 70 74 100 100 100 100 100 100 100 100 116 66 76 100 4 T5 12 88 3 03:10 Nil 04:50
70 72 66 62 62 66 70 74 100 100 100 100 100 100 100 100 114 70 70 100 5 T4 16 92 3 03:30 Nil 05:00
76 74 68 62 64 70 76 74 100 100 100 100 100 100 100 100 112 70 78 100 3 T4 12 90 3 03:15 Nil 05:20
80 76 74 70 72 70 74 76 100 100 100 100 100 100 100 100 180 70 72 100 3 T2 15 98 2 03:40 Nil 05:40
86 84 88 76 70 74 76 70 100 100 100 100 100 100 100 100 118 72 74 100 4 T4 12 94 2 03:15 Nil 05:20
92 88 88 90 90 84 74 84 100 100 100 100 100 100 100 100 122 76 82 100 3 T4 15 98 4 03:20 Nil 05:10
72 70 74 72 76 74 70 76 100 100 100 100 100 100 100 100 116 68 74 100 2 T4 10 90 2 03:10 Nil 04:50
78 80 76 72 78 74 72 76 100 100 100 100 100 100 100 100 120 68 74 100 3 T2 14 94 3 03:25 Nil 05:30
84 82 86 86 80 78 74 82 100 100 100 100 100 100 100 100 122 70 78 100 4 T4 12 90 2 03:15 Nil 05:20
86 84 88 88 82 80 76 84 100 100 100 100 100 100 100 100 124 70 80 100 5 T4 18 82 4 195 Nil 05:20
80 72 74 70 66 68 64 70 100 100 100 100 100 100 100 100 110 72 74 100 2 T2 14 102 2 04:10 Nil 05:20
76 68 64 68 70 66 70 72 100 100 100 100 100 100 100 100 116 68 70 100 2 T4 16 102 2 200 Nil 05:40
74 68 66 70 68 64 66 68 100 100 100 100 100 100 100 100 112 60 70 100 3 T4 12 96 3 03:40 Nil 05:30
64 72 61 58 64 60 66 68 100 100 100 100 100 100 100 100 130 68 70 100 3 T2 15 10 2 04:25 Bradycardia 05:50
92 90 94 92 88 88 85 88 100 100 100 100 100 100 100 100 120 60 84 100 2 T2 12 90 3 04:00 Nil 06:10
82 80 74 76 74 68 68 70 100 100 100 100 100 100 100 100 118 66 76 100 2 T2 14 98 2 03:55 Nil 05:30
80 82 76 64 68 72 74 80 100 100 100 100 100 100 100 100 116 72 82 100 3 T4 14 92 2 03:50 Nil 05:15
72 68 64 66 72 76 80 74 100 100 100 100 100 100 100 100 118 68 76 100 3 T4 12 88 2 03:40 Nil 05:10
86 74 78 70 72 76 82 80 100 100 100 100 100 100 100 100 110 70 84 100 3 T4 12 96 2 04:00 Shining 05:15
88 76 80 82 78 74 72 76 100 100 100 100 100 100 100 100 108 72 72 100 3 T4 12 88 2 03:20 Hypertension 05:10
82 80 82 86 86 82 78 76 100 100 100 100 100 100 100 100 118 68 80 100 3 T4 15 88 2 03:15 Nil 05:10
86 84 84 88 86 84 74 82 100 100 100 100 100 100 100 100 120 70 80 100 3 T4 15 90 3 03:25 Nil 05:12
70 72 66 68 68 74 76 74 100 100 100 100 100 100 100 100 118 68 72 100 3 T2 15 96 3 03:45 Nil 05:35
76 74 64 68 64 62 70 72 100 100 100 100 100 100 100 100 114 70 76 100 4 T4 12 94 2 03:35 Nil 05:25
90 78 84 82 80 82 84 76 100 100 100 100 100 100 100 100 108 68 76 100 4 T4 15 88 2 03:25 Nil 05:15
92 78 82 80 80 76 78 78 100 100 100 100 100 100 100 100 102 60 76 100 3 T2 20 85 2 03:40 Nil 05:20
68 64 60 56 68 64 68 68 100 100 100 100 100 100 100 100 108 70 70 100 3 T2 15 98 2 03:50 Bradycardia 05:45
68 64 66 60 58 68 68 66 100 100 100 100 100 100 100 100 108 64 66 100 3 T2 12 95 3 03:45 Bradycardia 05:50
82 80 72 74 76 70 78 74 100 100 100 100 100 100 100 100 120 70 70 100 3 T4 16 92 3 03:15 Nil 05:00
70 68 64 66 70 74 76 78 100 100 100 100 100 100 100 100 112 74 74 100 2 T2 15 96 2 03:50 Hyptension 05:45
76 74 78 72 74 80 78 82 100 100 100 100 100 100 100 100 118 74 76 100 3 T4 12 90 2 03:40 Nil 05:00
74 72 76 70 72 78 76 80 100 100 100 100 100 100 100 100 116 72 74 100 3 T2 15 94 2 03:50 Nil 05:45
72 70 74 68 70 76 74 78 100 100 100 100 100 100 100 100 114 70 72 100 3 T5 14 88 1 03:15 Nil 04:50
70 68 72 66 64 70 74 72 100 100 100 100 100 100 100 100 112 70 70 100 3 T2 12 98 3 03:50 Nil 05:45
66 64 70 72 68 74 70 74 100 100 100 100 100 100 100 100 118 70 76 100 2 T2 15 94 2 03:45 Nil 05:35
70 74 66 68 70 74 68 72 100 100 100 100 100 100 100 100 112 76 68 100 4 T5 12 86 2 3 Nil 04:50
76 72 68 64 70 76 78 72 100 100 100 100 100 100 100 100 116 74 74 100 2 T4 14 94 1 03:15 Nil 05:15
86 84 70 68 74 66 74 78 100 100 100 100 100 100 100 100 112 68 78 100 3 T4 12 92 2 03:40 Nil 05:10
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74 70 68 70 72 66 68 74 100 100 100 100 100 100 100 100 110 68 70 100 5 T5 15 90 3 03:20 Nil 04:05
82 80 74 66 68 72 76 74 100 100 100 100 100 100 100 100 120 70 78 100 1 T4 10 90 1 03:25 Nil 04:50
70 72 68 64 66 74 76 78 100 100 100 100 100 100 100 100 112 68 80 100 2 T5 12 80 1 03:15 Nil 04:40
70 72 76 68 62 62 76 70 100 100 100 100 100 100 100 100 122 70 76 100 2 T4 15 84 1 03:20 Nil 04:00
80 82 68 62 64 66 70 72 100 100 100 100 100 100 100 100 120 70 76 100 2 T4 12 86 1 03:30 Nil 04:25
82 76 72 64 62 66 74 78 100 100 100 100 100 100 100 100 118 78 82 100 3 T5 16 75 2 02:50 Nil 03:55
72 70 66 72 76 74 78 72 100 100 100 100 100 100 100 100 118 68 74 100 2 T2 15 92 2 03:10 Nil 04:00
76 70 64 68 66 76 72 74 100 100 100 100 100 100 100 100 118 70 76 100 1 T4 14 88 1 03:40 Nil 04:20
80 82 76 66 64 62 70 76 100 100 100 100 100 100 100 100 112 76 76 100 2 T5 12 78 2 03:15 Nil 04:15
78 74 62 64 68 70 74 72 100 100 100 100 100 100 100 100 122 70 76 100 1 T4 10 86 1 03:20 Nil 04:40
74 72 64 68 70 72 76 78 100 100 100 100 100 100 100 100 118 68 82 100 2 T4 10 80 2 03:00 Nil 04:10
70 72 66 68 64 62 66 74 100 100 100 100 100 100 100 100 112 64 70 100 2 T5 8 84 1 04:00 Nil 04:30
68 66 64 62 68 70 72 74 100 100 100 100 100 100 100 100 120 70 78 100 2 T5 16 78 1 03:10 Nil 03:45
68 73 60 626 62 60 56 58 98 98 97 97 96 96 96 100 110 60 68 100 2 T4 10 88 2 03:20 Bradycardia 04:20
76 74 72 76 68 66 70 74 100 100 100 100 100 100 100 100 118 68 78 100 3 T4 10 82 2 02:50 Nil 04:20
70 64 68 66 62 64 70 72 100 100 100 100 100 100 100 100 114 68 70 100 2 T5 12 80 1 03:15 Nil 04:00
68 64 70 72 70 76 74 72 100 100 100 100 100 100 100 100 117 70 72 100 1 T4 12 78 2 03:00 Nil 04:10
70 66 72 68 74 70 72 76 100 100 100 100 100 100 100 100 116 72 78 100 2 T2 10 92 1 04:10 Nil 04:50
68 64 60 68 70 72 76 70 100 100 100 100 100 100 100 100 108 76 74 100 3 T4 8 86 2 03:00 Nil 04:15
76 70 64 68 70 74 70 76 100 100 100 100 100 100 100 100 122 68 78 100 2 T5 15 78 1 02:45 Nil 03:20
68 64 66 64 62 68 70 72 100 100 100 100 100 100 100 100 118 70 74 100 3 T4 16 86 2 03:15 Nil 04:10
70 72 66 62 64 68 70 74 100 100 100 100 100 100 100 100 116 72 72 100 2 T4 14 68 1 02:45 Nil 03:40
76 74 70 68 74 66 70 76 100 100 100 100 100 100 100 100 116 74 78 100 3 T3 10 96 2 03:40 Nil 05:10
74 68 70 74 76 78 80 82 100 100 100 100 100 100 100 100 108 72 86 100 2 T4 8 88 1 03:00 Nil 04:10
68 64 70 76 68 70 72 76 100 100 100 100 100 100 100 100 118 70 72 100 2 T5 10 76 1 02:45 Nil 03:20
76 70 64 68 66 72 74 78 100 100 100 100 100 100 100 100 128 74 76 100 1 T4 12 76 1 03:10 Nil 04:40
76 70 72 76 70 76 70 72 76 100 100 100 100 100 100 100 118 72 76 100 3 T5 10 80 2 03:25 Nil 05:00
106 102 110 96 87 86 83 76 100 100 100 100 100 100 100 100 106 64 76 100 3 T5 10 82 2 6 Hypotension 05:00
68 64 60 62 60 68 70 74 100 100 100 100 100 100 100 100 116 64 74 100 3 T3 8 60 2 03:30 Bradycardia 02:30
70 60 58 56 60 72 76 74 100 100 100 100 100 100 100 100 118 70 72 100 3 T4 10 80 2 03:10 Bradycardia 04:15
76 72 68 70 66 74 72 76 100 100 100 100 100 100 100 100 122 70 78 100 2 T5 12 78 1 02:50 Nil 03:45
76 68 64 66 70 74 72 74 100 100 100 100 100 100 100 100 120 68 76 100 3 T4 14 80 2 03:10 Nil 04:20
74 70 76 72 68 66 70 74 100 100 100 100 100 100 100 100 116 70 70 100 3 T4 10 86 2 03:15 Nil 04:20
72 70 68 66 70 74 76 70 100 100 100 100 100 100 100 100 118 68 72 100 2 T5 15 78 1 03:00 Nil 04:10
68 72 66 64 62 70 72 70 100 100 100 100 100 100 100 100 118 60 76 100 2 T4 12 82 1 02:50 Nil 03:45
80 72 74 68 64 76 78 74 100 100 100 100 100 100 100 100 118 70 76 100 2 T5 12 76 1 03:00 Nil 04:10
88 86 80 62 58 64 60 60 100 100 100 100 100 100 100 100 130 70 66 100 2 T4 15 68 1 03:20 Bradycardia 04:10
80 76 64 68 70 76 70 72 100 100 100 100 100 100 100 100 120 68 78 100 2 T4 12 84 1 03:10 Nil 04:12
78 70 66 72 70 68 76 74 100 100 100 100 100 100 100 100 120 70 70 100 3 T5 10 86 2 03:00 Nil 04:15
106 102 110 96 87 86 83 76 100 100 100 100 100 100 100 100 106 64 76 100 3 T5 10 85 2 6 Hypotension 05:00
76 70 64 68 70 74 70 76 100 100 100 100 100 100 100 100 122 70 78 100 2 T5 12 78 1 02:50 Nil 03:45
74 72 64 68 70 72 76 78 100 100 100 100 100 100 100 100 120 68 78 100 3 T4 8 86 2 03:00 Nil 04:15
66 64 62 66 60 68 64 68 100 100 100 100 100 100 100 100 124 70 70 100 05:30 T6 16 52 7 02:20 Nil 02:45
80 74 76 64 68 76 74 78 100 100 100 100 100 100 100 100 124 70 82 100 04:30 T5 12 52 4 02:20 Nil 03:10
76 78 70 68 72 74 72 76 100 100 100 100 100 100 100 100 124 70 78 100 4 T6 15 52 5 02:40 Nil 03:15
92 84 80 70 68 74 68 84 100 100 100 100 100 100 100 100 126 72 86 100 3 T6 15 55 3 02:35 Nil 03:30
70 68 70 66 64 62 74 70 100 100 100 100 100 100 100 100 118 72 72 100 4 T5 12 50 2 02:15 Nil 03:10
72 70 72 68 66 64 76 72 100 100 100 100 100 100 100 100 120 70 74 100 6 T6 18 55 3 02:40 Nil 03:15
68 66 70 64 66 68 70 72 100 100 100 100 100 100 100 100 116 72 74 100 6 T6 1 48 3 02:00 Nil 02:45
70 74 76 68 64 66 74 70 100 100 100 100 100 100 100 100 122 70 78 100 5 T6 16 45 3 01:45 Shining 02:50
66 68 72 70 74 64 66 78 100 100 100 100 100 100 100 100 120 74 84 100 4 T4 16 50 4 02:50 Hypotension 03:00
64 66 68 62 62 64 68 70 100 100 100 100 100 100 100 100 120 72 74 100 5 T6 15 52 3 02:40 Nil 02:55
72 68 70 74 76 74 78 72 100 100 100 100 100 100 100 100 124 70 76 100 4 T6 12 52 4 01:45 Nil 02:40
70 68 68 66 72 74 76 78 100 100 100 100 100 100 100 100 122 70 80 100 4 T6 15 45 4 02:10 Nil 02:45
70 74 72 68 66 70 74 80 100 100 100 100 100 100 100 100 118 82 82 100 5 T6 12 52 4 01:45 Shining 02:15
80 76 64 66 70 72 68 70 100 100 100 100 100 100 100 100 118 72 76 100 5 T6 12 48 4 01:50 Nil 02:45
76 74 68 70 72 66 68 68 100 100 100 100 100 100 100 100 120 70 70 100 5 T6 16 52 4 02:00 Nil 02:45
74 70 72 74 70 72 76 76 100 100 100 100 100 100 100 100 118 70 74 100 4 T5 18 56 3 02:40 Nil 03:10
74 70 62 68 66 70 72 74 100 100 100 100 100 100 100 100 124 70 70 100 5 T6 15 50 4 02:00 Nil 02:50
70 68 72 64 66 68 72 74 100 100 100 100 100 100 100 100 126 70 78 100 4 T6 12 45 2 02:10 Nil 02:50
78 70 66 64 70 74 72 70 100 100 100 100 100 100 100 100 122 70 74 100 4 T6 20 45 4 01:50 Nil 02:35
80 70 66 68 70 74 72 76 100 100 100 100 100 100 100 100 120 64 70 100 6 T6 18 52 5 02:20 Shining 03:10
84 74 70 72 74 78 76 74 100 100 100 100 100 100 100 100 126 70 76 100 4 T6 15 48 3 02:10 Nil 02:45
68 66 64 68 66 70 76 74 100 100 100 100 100 100 100 100 124 70 78 100 3 T5 10 50 3 02:00 Nil 03:10
78 76 78 70 68 74 72 70 100 100 100 100 100 100 100 100 126 70 76 100 5 T6 12 48 4 01:50 Nil 02:45
70 72 68 64 70 72 76 74 100 100 100 100 100 100 100 100 122 70 70 100 4 T6 18 60 4 02:20 Nil 03:00
70 68 66 70 68 72 78 76 100 100 100 100 100 100 100 100 126 70 76 100 4 T6 15 55 4 02:15 Nil 02:50
74 70 72 68 70 74 76 74 100 100 100 100 100 100 100 100 120 76 78 100 4 T6 12 54 3 02:10 Nil 02:30
74 70 58 68 70 74 76 70 100 100 100 100 100 100 100 100 120 70 74 100 03:30 T5 15 53 3 01:50 Bradycardia 02:30
76 74 68 72 66 70 76 74 100 100 100 100 100 100 100 100 124 70 78 100 4 T6 12 51 3 02:00 Nil 02:45
75 66 70 74 76 72 68 70 100 100 100 100 100 100 100 100 118 70 74 100 3 T6 10 48 3 01:30 Nil 02:15
80 74 68 70 74 76 80 84 100 100 100 100 100 100 100 100 120 76 80 100 5 T6 12 52 3 02:00 Nil 03:00
76 70 64 66 72 78 76 74 100 100 100 100 100 100 100 100 124 70 82 100 3 T6 8 48 2 01:50 Nil 02:48
74 68 62 64 70 76 74 72 100 100 100 100 100 100 100 100 122 68 80 100 4 T6 12 50 3 02:15 Nil 02:50
82 72 66 68 74 80 78 76 100 100 100 100 100 100 100 100 126 72 84 100 5 T5 15 45 2 02:30 Nil 03:00
80 70 64 66 72 76 78 74 100 100 100 100 100 100 100 100 122 70 80 100 4 T6 10 52 3 02:40 Nil 03:15
82 72 68 70 72 76 76 76 100 100 100 100 100 100 100 100 124 68 78 100 5 T6 8 55 3 01:55 Nil 02:50
80 82 76 68 64 70 76 78 100 100 100 100 100 100 100 100 122 76 80 100 4 T5 16 58 3 02:15 Nil 02:10
78 76 70 76 74 74 72 76 100 100 100 100 100 100 100 100 120 68 78 100 5 T6 12 52 4 02:00 Nil 02:50
74 70 68 66 68 76 74 72 100 100 100 100 100 100 100 100 114 70 76 100 4 T5 12 54 3 02:20 Nil 03:12
82 78 66 68 72 70 74 70 100 100 100 100 100 100 100 100 110 74 74 100 4 T6 15 50 3 01:50 Nil 02:45
60 65 64 56 72 78 76 74 100 100 100 100 100 100 100 100 124 70 82 100 3 T6 8 48 3 01:50 Bradycardia 02:30



